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Identifying DNA sequences (enhancers) that direct the precise spatial and temporal expression 
of developmental control genes remains a significant challenge in the annotation of vertebrate 
genomes. Locating these sequences, which in many cases lie at a great distance from the 
transcription start site, has been a major obstacle in deciphering gene regulation. The 
completion of a number of vertebrate genome sequences with its unprecedented coverage and 
resolution, as well as the concurrent development of genomic alignment, visualization, and 
analytical bioinformatics tools, has made large scale genomic sequence comparisons between 
diverse species, not only possible but an increasingly popular approach for the discovery of 
putative cis-regulatory elements. Here we present a study which integrates comparative 
genomics (teleost fish to humans) , with medium throughput functional assay to identify a list 
of conserved non-coding sequences to test for regulatory activity in important genes which 
control the specification and development of various tissue types in vertebrates, that are 
ancient in origin and conserved in evolution 
Our results clearly indicate that high level of functional conservation of genes is not 
necessarily associated with sequence conservation of their regulatory elements. Moreover, 
highly conserved non-coding elements may not have known role in cis-regulation .This study 
emphasizes the need to look beyond just sequence conservation and use multiple approaches 
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Chapter 1:   INTRODUCTION  
 
One of the key paradigms of development is the regulation of the genome in a precise and 
synchronized manner to form a highly complex embryo with diverse and specialized cell 
types. Though the major cell types in the embryo essentially contain the same genetic material 
they are very different from each other in both morphology as well as function. It is the 
generation of this diversity from the same starting material that is the hallmark of 
development and makes it an ideal system to investigate the multiple layers of gene 
regulation.   
To understand gene regulation it is important to answer two questions- what is the complete 
sequence of the genome and what are its functional components. The first question was 
answered in 2001 by the publication of the first draft of the human genome [1, 2] and 
followed by the sequencing of the genomes of various other species. This led to a better 
understanding of how many protein coding genes different species, specially humans, have 
with high confidence [3]and what are their potential functions. But locating and validating the 
functional non-coding components of the genome has been a major challenge in completely 
annotating the vertebrate genomes. The ENCODE project [4]is an large scale effort in 
annotating such functional elements in the human genome and have been able to decipher 
many such elements but is by no means an exhaustive survey. Functional non-coding 
elements in the genome include non coding RNA, cis-regulatory elements, splicing elements 
and sequences directing chromatin structure. Unlike protein coding genes which have a 
characteristic structure that helps in their identification, very little is known about the 




This project aims to utilize comparative genomics of phylogenitically diverse vertebrate 
species to locate and validate candidate cis-regulatory elements for developmental control 
genes that are ancient in origin and conserved in evolution. 
1.1   Cis-Regulatory Elements  
Cis-regulatory elements are DNA sequences that are a key component of the genome’s non-
coding functional elements and are defined by two major characteristics- they are non-coding 
and cis i.e. they are located on the same chromosome as the gene they control. They help in 
driving the precise spatial and temporal expression of various genes and play a key role in 
differential gene expression which controls many biological processes like cell growth, 
differentiation, and apoptosis. This control of spatio-temporal gene expression leads to the 
diversity in cell and tissue types seen during development. Cis-regualtory elements primarily 
consist of basal promoter, proximal promoter, enhancers, silencers, insulators and locus 
control region (LCR). A basal promoter immediately flanks the transcription start site (TSS) 
of a gene and acts as a binding site for the basic transcriptional machinery including RNA 
polymerase II. The proximal promoter extends a few 100 bases upstream of the basal 
promoter and contains the binding sites for sequence dependant transcription factors. The 
basal plus the proximal promoters extends up to 1kb upstream of the TSS and is together 
referred to as the promoter [5, 6]. Transcriptional enhancers are distal from the TSS of the 
gene and also contain multiple transcription factor binding sites and by binding various 
transcription factors and co-activators, helps in controlling gene expression in a regulated 
manner. Insulators (also called boundary elements) and silencers are negative regulatory 
elements that help in repressing gene activity by preventing the enhancer to act on the 
promoter and also act as boundary defining the region inside which most of the gene’s 
regulatory elements will reside. So far only one protein is known to bind to these insulator 
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elements – CCCTC binding factor (CTCF) marking boundaries between different chromatin 
domains [7] and separates genes with discordant expression patterns [8]. Locus control 
regions are made up of multiple cis-regulatory elements and are capable of directing 
expression of one or more genes independent of their proximal promoters. Among all these 
various classes of functional non-coding elements, transcriptional enhancers play the most 
significant role in controlling the specificity of gene expression. Promoters generally direct 
basal level of gene transcription, but both the amount of transcript and subtle changes in 
expression domains of a gene is controlled by the enhancers and the transcription factors they 
bind. A gene can potentially have multiple enhancers each with its specific transcription factor 
binding site. Hence the total number of gene expression patterns that can be obtained is far 
greater than the total number of trans-acting factors in the human genome [9]. 
Experiments over the years have established some common characteristic features of 
transcriptional enhancers. Firstly enhancers are modular in nature i.e. distinct enhancers can 
act on a single promoter in different cell types under different conditions to bring about 
differential gene expressions. The examples of these can be found in Drosophila the pair-rule 
gene even skipped (eve) which expresses in seven segments of the early embryo is controlled 
by five enhancers and each enhancer controls the gene expression in only one or two segments 
[10]. Similar examples of the modular nature of enhancers are also present in vertebrate 
system for the gene Sox9 whose expression in various tissues in the developing mouse is 
controlled by seven separate enhancers [11]. Secondly enhancers are distance independent  
and can be located in 5` or 3` flanking region, intronic region and even untranslated exonic 
region of a gene. There are many examples of developmental enhancers positioned at great 
distances to the gene they regulate. The classical example of a long range enhancer is the 
enhancer that directs specific Sonic hedgehog (Shh) expression in the posterior regions of the 
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developing mammalian forelimbs and hindlimbs that is located 1Mb away in the intron of a 
neighboring gene [12]. Thirdly enhancers are orientation independent. A SV40 viral enhancer 
sequence that was cloned 1.4 kb upstream and 3.3 kb downstream of a rabbit β-globin gene 
was able to enhance the gene expression in both cases [13]. Finally experimental evidence is 
gathering to point towards a “looping-out” mechanism of enhancer action, in which the DNA 
between the promoter and the enhancer loops out so that the transcription factor at the 
enhancer is brought closer to the basal transcriptional machinery at the promoter [14]. 
1.2  Cis-regulatory elements in disease and evolution 
It is becoming increasingly clear that many human diseases are caused not due to a mutation 
in a protein coding gene but due to mutation in the cis-regulatory elements of various genes. 
Also many disease associated loci fall within non-coding regions which are potentially 
involved in gene regulation. Patients with preaxial polydactyly, a condition marked by extra 
digits in the hand and feet have a point mutation in the long range enhancer of Shh [12]. It was 
also demonstrated that in children with oculo-auriculo-vertebral spectrum, a common 
developmental disorder characterized by hemifacial microsomia, epibulbar tumors, ear 
malformation and vertebral anomalies there is a chromosomal translocation t(4;8) where the 
breakpoint in chromosome 4 is 76.4 kb distal to the Nkx3.2gene and there is no  mutation in 
the gene itself, suggesting that the breakpoint contained a distal regulatory element for the 
gene [15]. Recently studies have also indentified point mutations in highly conserved non-
coding elements associated with SOX9 that lead to Pierre Robin sequence (PRS) an important 
sub-group of cleft palate. This enhancer also maps to one micro deleted region associated with 
the disease [16]. The above examples highlight the close association of cis-regulatory 
elements in human disease and underscore the importance of trying to locate and validate 
15 
 
them to get insights into the proper functioning of many genes, the disruptions in which leads 
to significant developmental consequences. 
Ideas about the evolutionary significance of non-coding mutations are nearly as old as the 
discovery of regulatory sequences themselves. Two influential papers published during the 
1970s argued, on the basis of indirect evidence, that cis-regulatory mutations might have an 
important role in evolution. The first, published by Britten and Davidson [17],was stimulated 
by the discovery that a substantial proportion of many eukaryotic genomes is composed of 
repetitive sequences. Britten and Davidson proposed that repetitive sequences regulate 
transcription. They advanced the first model for the evolution of regulatory sequences and 
argued that regulatory mutations play a crucial part in phenotypic evolution. The second 
influential paper, published by King and Wilson [18] was motivated by the realization that 
homologous proteins in humans and chimpanzees are nearly identical. King and Wilson 
argued that the modest degree of divergence in protein sequence cannot account for the 
profound phenotypic differences between the species, and proposed instead that regulatory 
mutations must be primarily responsible for these differences. It is evident today that the basic 
postulates in both the papers were sound. We now have numerous clear examples of cis-
regulatory mutations that have contributed to functionally significant and ecologically 
relevant traits [19]. A more interesting and tractable question is whether regulatory mutations 
make a qualitatively distinct contribution to phenotypic evolution. Several authors have 
argued this point from examples and first principles [17, 18, 20].Their arguments fall into two 
basic categories that are not mutually exclusive: that cis-regulatory mutations are intrinsically 
more likely to affect certain kinds of phenotypic traits, and that selection operates more 
efficiently on cis-regulatory mutations. Recent studies also suggest that the clusters of 
conserved non coding elements around developmental control genes are part of core gene 
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regulatory networks that specify the animal body plan [21]. Taken together all these studies 
show strong evidence that cis-regulatory elements have had a major role in evolution of 
species and are in part responsible for the diversity seen in the animal world. 
1.3   Methods to identify cis-regulatory elements 
Cis-regulatory elements lack a well defined structure similar to that of protein coding genes. 
They generally consists of a single or a group of transcription factor binding sites arranged 
within them and there is very limited knowledge on the structure of the arrangement of these 
binding sites on a particular regulatory element. Transcription factor binding sites are 
typically small around 5-15 bp long and can be degenerate, wherein variation in some bases 
are tolerated more than the other. Recent studies have also shown that enhancers for the same 
gene from two related species can direct identical gene expression patterns without any 
sequence level constrain in them [22], thus transcription factor  binding site sequences can be 
completely different even for enhancers doing similar functions. Furthermore cis-regulatory 
elements are position and orientation independent, hence the search for these elements require 
extensive analysis of large stretches of the chromosome on which the gene is located. The 
bigger challenge than locating the cis-regulatory element is to ascertain the core sequence of 
the element which is required for its activity. The methods employed to locate and validate 
cis-regulatory elements are many and utilize different properties of these elements to 
distinguish them from the surrounding DNA. The traditional approaches relied on genetic and 
biochemical properties of these elements to locate them in the genome. The advent of the 
genomics era with its emphasis on large scale genome sequence data has led to utilization of 
sequence level information of these elements as a means to locate them and try to decipher 
their function. Thus the methods can broadly be classified in to two major groups- pre 
genomics and genomics era methods. 
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1.4   Pre genomics era methods to locate and validate cis-regulatory elements 
The traditional or pre genomic era techniques to locate cis-regulatory elements primarily 
relied on biochemical and genetic assays to capture them. One of the earliest biochemical 
methods to study cis-regulatory elements was DNA footprinting [23]. The method works on 
the principle that all regulatory elements will bind transcription factors and aims to precisely 
locate the exact binding site of a transcription factor on a DNA element, thus determining the 
core functional domain of the element. The DNA fragment (putative regulatory element) is 
end labeled either radioactively or non radioactively at one end (called a probe) and incubated 
with the protein suspected to bind the fragment. The DNA element is then cleaved either by 
endonuclease or chemical reagents. The resulting DNA fragments are separated by gel 
electrophoresis alongside a control DNA sample which had not been incubated with the 
protein. Both the DNA samples generate different cleavage pattern, with the protein bound 
DNA sample missing bands (“footprint”) at DNA sequences where it is protected from 
cleavage by the protein. The position of the footprint is read of the gel in relation to the 
labeled end of the probe. The advantage of this method is that single base pair resolution of 
binding sites can be obtained. One of the disadvantages of the method is that this is an in vitro 
method and it might not reflect a true binding event in vivo, additionally the binding of a 
transcription factor to a DNA element does not always prove its functionality and these assays 
should always be coupled with functional validations.  
Another biochemical assay which captures the chromatin state of the DNA in vivo is the 
DNase I hypersensitivity assay [24, 25]. In the eukaryotic nucleus, DNA is coiled around 
histone octamer complexes at regular intervals to form nuleosomes. The nucleosomes play an 
important role in packaging the huge eukaryotic genome in the small nuclear place and hence 
also influence processes like transcription and DNA replication. Modification of histone 
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proteins like H3K4me3 are considered transcription initiation mark [26, 27] and generally 
lowers DNA’s affinity for nucleosome thus creating a open chromatin state and making the 
underlying DNA more accessible to transcription factors and marks out the regions as 
potential functional non coding element. This open nucleosome state also makes the DNA 
susceptible to DNase I cleavage.  Thus regions with cleavage sites are marked out as potential 
cis-regulatory element. Since DNase I hypersensitivity is a transient property of DNA 
sequences, this assay can be used to detect spatio-temporal patterns of gene expression and 
also used to locate various cis-regulatory elements in various cell types. The level of 
resolution of this assay has dramatically increased and the assay itself has become faster over 
the years, from about 500bp on either side of the nucleosome depleted region using a southern 
blotting analysis [28] to nearly nucleotide level resolution using a PCR based assay [29] to 
finally using quantitative PCR [30]. Still as with DNA footprinting this assay only points 
towards a putative region as a regulatory element and it still has to be functionally verified. 
Also the assays themselves are not trivial and both southern blotting and quantitative PCR 
requires optimization and hence it is not feasible to perform this assay on a large scale. 
As stated earlier the most critical test for a DNA element to be classified as a cis-regulatory 
element is its ability to direct gene expression. This goal is achieved through performing 
reporter gene assays, which is a gold standard for detecting enhancer activity. In such an assay 
the putative DNA element is cloned upstream or downstream of a reporter gene linked to a 
basal promoter. The reporter gene can be β-galactosidase, green fluorescent protein or firefly 
luciferase. The construct is then transfected into cells transiently or stably and then the 
reporter gene product is used as readout to detect gene expression. The length of the cis-
regulatory element is varied to find the core sequence which is sufficient to drive gene 
expression. Suppressors/silencers are detected in a similar manner by cloning the putative 
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region upstream of a strong enhancer and then assaying for a decrease in expression of the 
reporter gene. Enhancer blockers can be detected by cloning the putative piece between a 
strong enhancer and the promoter driving the reporter gene and detecting a loss or drop of 
gene activity [31]. The biggest drawback of testing enhancer activity in cell culture is that it is 
virtually impossible to detect saptio-temporal activity of a developmental enhancer and also 
all cell types are not easy to culture and hence cell type specific regulatory activity is difficult 
to detect with cultured cells. To overcome this limitations a transgenic animal model is used 
to assay for regulatory activity, which helps to show actual in vivo function of a DNA 
element. A construct similar to one used in cell transfection assays is injected into one cell 
fertilized mouse or zebrafish embryo, which allows the construct to be randomly integrated 
into the genome. The reporter gene expression is then followed over time either under a 
microscope for fluorescent molecules or by staining for lacZ. The expression pattern of the 
element is correlated to the expression pattern of the gene under study to characterize it as its 
regulatory element. There are a couple of drawbacks to this system as well, since the 
integration of the transgene occurs at random location in the genome, there is always a risk of 
the element showing ectopic expression due it coming under the control of an endogenous cis- 
regulatory element or it being silenced (positional effect). Hence it is crucial that similar 
expression is obtained in several independent transgenic lines before drawing a conclusion on 
its activity. Secondly the microinjection of the vector is carried out at the one cell stage so that 
the transgene is integrated into the genome before the cell divides and hence all cells in the 
resulting embryo will contain the transgene. But in certain cases especially in the rapidly 
dividing zebrafish embryo there is always the chance of the integration happening after cell 
division has started, resulting in a mosaic expression of the transgene. But the biggest 
advantage in zebrafish is the availability of a large number of embryos which can be injected 
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with the same construct and hence screened to detect the actual expression domain over the 
mosaic expression. Also the development of zebrafish is external (outside the mother’s body) 
it is easy to study many embryos under the microscope simultaneously. 
1.5   Genomics era methods to locate and validate cis-regulatory elements 
The release of the human genome sequence and the genome sequences of numerous other 
species has allowed search and validation of cis-regulatory elements to be high throughput 
and on a whole genome scale. These methods use the completed genome as a base onto which 
numerous experimentally obtained sequences can be mapped and based on which large 
numbers of microarray probes can be designed. With the whole genome sequences of many 
species being available, some of the drawbacks of the old assays like DNase I hypersensitivity 
have been addressed by coupling genome era knowledge with a pre genome era technique in 
which the whole yeast nuclei is cleaved with DNase I followed by massive parallel 
sequencing to detect protected sites in the genome [32]. 
 Chromatin immunoprecipitation (ChIP) is  method that can elucidate the sites of transcription 
factor DNA interaction in vivo. The genomic DNA is covalently cross-linked to the DNA 
binding proteins by formaldehyde. The DNA is then extracted and fragmented by sonication 
to 100-500 bp size fragments. An antibody that is highly specific to the transcription factor 
under study is used to precipitate all the DNA fragments to which it is bound. The cross-
linking is reversed and the DNA fragments are then purified and cloned into a vector (ChIP 
library). All these are clones are then sequenced and mapped back to the reference genome to 
elucidate all the regions where the transcription factor binds. Thus those regions could act as 
potential regulatory elements. Though ChIP is a very powerful method to detect whole 
genome binding sites, there are some potential problems. The biggest hurdle in doing ChIP is 
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to obtain a highly specific antibody for the transcription factor and without it, there is always a 
risk of pulling down non-specific protein bound DNA. The cross linking step can also produce 
non-specific DNA-protein linkage which might be an artifact of the experiment and does not 
truly represents an actual in vivo interaction. The other major challenge in doing ChIP is that 
often it is difficult to get sufficient material from developing embryos/ tissue that is required 
by most ChIP protocols 
 Modifications of ChIP assay have allowed researchers to identify transcription factor binding 
site on a genome wide scale. In ChIP on chip analysis the protein bound enriched DNA 
fragments are hybridized to a tilling array. This method was successfully applied to human 
chromosome 21 and 22 to find binding sites for three transcription factors -Sp1,c-Myc and 
p53 [33]. These methods generally find a huge number of binding sites for a specific 
transcription factor, out of which only a subset are generally functional. Recent studies have 
also demonstrated the viability of doing ChIP on embryonic tissues followed by massive 
parallel short read sequencing (ChIP-seq) and can be used to identify tissue specific enhancers 
with high confidence [34]. 
Studies into the genome wide distribution of histone modifying marks have suggested that 
certain marks on histones are a good indicator of the corresponding region of DNA being a 
cis-regulatory element. Histone H3 diacetylated on lysine 9 and 14 (H3K9acK14ac) in human 
peripheral T-cells mark known active gene promoters, enhancers and locus control region 
[35]. Furthermore functional analysis of randomly selected human  acetylation islands showed 
that about 43% of them could act as functional enhancers in Jurkat T-cells [36]. Recent 
studies have pointed out 17 different types of acetylation and methylation  marks present in 
promoters of ~ 3300 genes that are highly expressed  compared to genes that don’t have these 
marks [37]. Studies have also shown that active promoters are marked with H3K4 
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trimethylation while enhancers are marked with H3K4 monomethylation and these marks 
were then used to predict ~220 active promoters and ~ 420 enhancers. 90% of the predicted 
promoters mapped to known transcription sites and 63% of predicted enhancers correspond to 
previously reported DNaseI hypersensitive sites or binding sites for p300 and mediator 
subunit TRAP220 [38]. The genome wide profiling of histone modification has led to the 
discovery of dynamically changing active and repressed chromatin domains and associated 
regulatory elements in different cell types [39]. 
Another genomics era technique used to detect intra and inter-chromosomal interactions in a 
cell’s natural state is chromosome conformation capture (3C) [40, 41], which aims to capture 
long range enhancers and their associated transcription factors as they are brought in close 
proximity of their target genes.. In 3C, formaldehyde is used to cross link the interacting DNA 
and protein complexes. Then the DNA extracted from the nuclei is digested with a restriction 
enzyme and ligated to capture interaction between different DNA molecules. The cross 
linking is reversed and the products are analyzed by PCR with primers specific to region of 
interest (“bait” sequence) [42]. Since 3C can only be used to study a limited number of 
interactions at a time, 3C- carbon copy (5C) was developed where a multiplex ligation-
mediated amplification step is included after the cross linkage is reversed. This step uses 
different primers like T3 and T7 sequence primers (universal primers) plus ligation junction 
sequences to amplify selected ligation junctions. A quantitative replicate of the initial library 
is thus created and analyzed through high-throughput sequencing or tilling arrays [43]. The 
above two methods require painstaking design of primers for both the bait sequence as well as 
the capture sequence, hence a new method, circular 3C (4C) was developed that does not 
require primers to capture sequences. In 4C the initial protocol is similar but it uses a six base 
cutter for the first restriction digest and after ligation and reverse cross linking, it uses a four 
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base cutter to produce smaller restriction fragments. This is followed by self circularization 
step. Inverse PCR using bait-specific primers is carried out and the products are analyzed by 
high throughput sequencing or microarray with probes that target sequences flanking the first 
restriction enzyme [42, 44, 45]. The biggest advantage of 3C is that it can assign long range 
enhancers to its target gene in vivo and detect the frequency of this interaction. But as with 
any other binding site assay, downstream validations are required for functionality of the 
captured regulatory elements. Also these experiments require very tight controls to eliminate 
any interactions which are artifacts of the experimental set up. 
1.6   In silico predictions of  cis-regulatory elements 
The methods described above though being high throughput requires extensive 
experimentation on part of the researchers to zoom in to regions which can potentially act as 
regulatory element. In contrast in silico prediction of these elements helps in narrowing down 
the region in the genome to a manageable size on which the experiments can be conducted. 
Because most if not all cis- regulatory elements have transcription factor binding sites 
(TFBS), predicting individual TFBS or a cluster of TFBS is the first step towards analyzing a 
locus for its regulatory activity. Databases like JASPAR or TRANSFAC catalog TFBS 
obtained from published literature and position weight matrices (PWMs) that are derived from 
known TFBS. TFBS prediction can be achieved by either string matching against known 
TFBS or statistical matching against PWMs. To create a PWM, alignments of known binding 
sites of a transcription factor are first constructed and the frequency of observing a particular 
nucleotide at each base of the alignment is represented as log-likelihood ratio relative to the 
genomic background. To score an input sequence against a PMW, the sequence is scanned on 
both strands for possible sites, the log-likelihood ratios of all bases in the site are summed up 
and sites whose score exceeds a user-defined threshold are reported. Several programs like 
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MatInspector [46] and P-Match [47] are routinely used  to TFBS databases. However TFBS 
databases are constantly evolving and rarely complete. Some transcription factor families may 
be under represented or in some cases all the TFBS for a transcription factor may not have 
been identified due to degenerate nature the of binding site motif as demonstrated by a recent 
study where the binding site for SIX3 in the forebrain enhancer of SHH was validated by 
supershift assay but this site could not be detected by TRANSFAC [48]. This degeneracy can 
also lead to identification of many more binding sites than there actually are for a transcription 
factor. More importantly defining the threshold value is a challenging task. A good threshold 
value has to achieve a good balance between sensitivity to specificity to minimize both false 
negative and false positive discovery respectively. Since many sites that correspond to a 
known TFBS motif may not be functional thus driving up the false positive rate, hence TFBS 
prediction is generally used in conjunction with other criteria that provide additional 
information on the possibility of a DNA element having a role in cis-regulation. A study in 
2004 enforced a threshold score of 60% for the maximum possible score for a TFBS and also 
added a condition that the predicted site has to reside near a site bound by the same 
transcription factor in a ChIP assay [49]. Another group developed a program rVISTA to 
identify TFBS that are also evolutionary conserved [50]. rVISTA allows inputs alignments 
from programs like BLASTZ, ECR browser, GALA database (Penn State University) and 
uses BLASTZ’s alignment to look for high degree of conservation (> 80%) in a 20 bp sliding 
window. In addition the TFBS are clustered for individual or combination of transcription 
factors by a filtering scheme that identifies evolutionary conserved regions that contain a 
minimum number of sites for at least a few transcription factors. 
As an alternate to using TFBS prediction program that are restricted to using existing 
information in the databases, de novo motif discovery has been used as a means to find new 
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TFBS. This method aims to identify patterns in non coding DNA that occur more frequently 
than expected and that signify a possible function. This is based on the observation that many 
cis-regulatory elements tend to possess multiple binding sites for the same transcription factor. 
Many de novo motif finding algorithms are available and they differ from each other in 
various aspects- the definition of a motif, the criteria for statistical over representation and the 
method used to find the over represented motifs, for example expectation maximization used 
by MEME [51], Gibbs sampling used by AlignACE [52]  and exhaustive enumeration of short 
k-mers by Weeder [53]. Motif discovery has also been used on the conserved non coding 
elements (CNEs) in the human genome to detect novel motifs to help in prediction of regions 
as potential enhancers [54]. Motif finding within the mammalian conserved regions of 
promoters and 3` untranslated region (UTR) has uncovered 174 motifs in promoters and 106 
motifs in 3` UTR potentially involved in post translational control [55]. A search for motifs in 
the CNEs within 1 Kb upstream of 18 groups of co-expressed genes (genes expressed in 
neuronal tissue, pancreas or skeletal muscles) resulted in 431 previously reported TFBS motif 
and 579 novel motifs [56]. These studies looking for de novo motif has met with certain 
amount of success in identifying functional cis-regulatory elements with comparison with 
existing ones. However the bigger question is what is the cross compatibility between 
different programs and what is the overlap in their predictions. One study attempted to make 
comparison by applying 13 different motif finding software to the same sequence looking for 
TFBS. The main conclusion was that researchers should use a few motif finding algorithms 
rather than rely heavily on one and should consider a few best results rather than the most 




1.7 Comparative genomics and conserved non coding elements 
With the availability of the various genome sequence and the concurrent development of 
genomic alignment, visualization, and analytical bioinformatics tools has made comparative 
genomics not only possible but an increasingly popular approach for the discovery of putative 
cis-regulatory elements. Comparative genomics is not biased towards any genomic region, 
does not rely on any prior knowledge of which transcription factors are regulating the target 
gene. The basic premise of this method is that functional non coding DNA tend to evolve 
more slowly than non functional DNA due to selective pressure, hence cis- regulatory 
elements can be identified as conserved non-coding elements in sequence comparison of 
related genomes. Although this approach has gained popularity in the genomics era, it has 
been applied successfully before the availability of genome sequence. For example 
phylogenetic footprinting was used to identify cis-regulatory elements through comparisons of 
promoters and 5` flanking regions of γ-globin and  ε-globin gene of several primates and other 
mammals [58]. Thus alignment of orthologous nucleotide sequences in two or more species 
allows for identification of non coding sequences that are noticeably more conserved than the 
background sequences. These CNEs have been functionally shown to act has enhancers in 
transgenic assays in fish and mouse [54, 59, 60]. 
Comparison between human and closely related species such as mouse has been extensively 
used to identify CNEs in the human genome [61]. Loots et al searched for human-mouse 
CNEs in a ~ 1Mb genomic region at human chromosome 5q31 that were >70% identical over 
100 bp or more. Fifteen CNEs were found to be conserved in human, mouse and several other 
mammals. One of the CNE was determined to regulate the expression of interleukin-4, 
interleukin-13 and interleukin-5. While human –mouse sequence conservation can be 
particularly useful for finding mammalian specific cis-regulatory elements, this approach 
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tends identify many false positives due to the relatively short evolutionary distance between 
the two species (~ 60 Myr). On the other hand as the phylogenetic distance between two 
species increases the average conservation of the DNA under neutral evolution since their last 
common ancestor decreases. Sequence comparison between human and more distantly related 
species like teleost fishes that have been separated by larger evolutionary distance (~450 
Myr), increases the probability that the CNEs that are identified are functional one [62]. The 
first proof of principle study to show the feasibility of comparative genomics between human 
and teleost fish was reported in 1995. Two transcriptional enhancers that control Hoxb4 
expression in the mouse mesoderm, ectoderm and the neural tube were found to contain three 
mouse –fugu conserved regions (CR1, CR2 and CR3). CR1 was shown to be essential for 
expression in the mesoderm, central and peripheral nervous system while CR3 directed gene 
expression to the posterior hind brain [63]. Mouse – fugu comparison has also located cis-
regulatory elements for Pax9/Nkx2-9 locus. Out of total 15 CNEs in the mouse-human 
comparison 2 CNEs were also present in the human-mouse-fugu comparison one of which 
directed gene expression in ventral neural tube for Nkx2-9 and the other in the medial nasal 
processes for Pax9 [64]. Human –fugu comparison also revealed seven out of nine CNEs were 
functional in the gene desert surround the Dachshund gene locus [65]. Human- fish 
comparison has also been done to locate CNEs in the whole genome rather than gene by gene 
basis and have shown that many of these sequences can recapitulate gene expression in vivo, 
thus further strengthening the argument that phylogentically distant conserved non coding 
elements have a higher chance of having a function [54, 66]. 
Thus the two main methods employed to locate conserved functional enhancers in the genome 
are either through whole genome comparisons or by locus by locus alignment. Whole genome 
alignments typically use local alignment programs like BLASTZ [67] and MegaBLAST [68] 
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to rapidly align regions of high homology. When such an alignment is carried out between 
phylogentically distant species such as human and fish they generally fail to identify and align 
all the orthologous sequences due to stringent criteria that are set for local alignments. On the 
other hand , locus by locus global alignments of orthologous gen loci using programs like 
LAGAN/MLAGAN [69] and AVID [70] are effective in identifying all the associated CNEs. 
But it is prudent to bear in mind that since global alignment has an additional assumption that 
input sequences occur in the same order and orientation, they can detect more weakly 
conserved regions [70, 71]. Nevertheless, it should be noted that global alignment algorithms 
tend to miss out conserved functional elements that have undergone local inversions or 
rearrangements. 
1.8 Transcription Factors (TF) 
Transcription factors (sometimes called sequence-specific DNA binding proteins) are proteins 
that bind to specific DNA sequences and thereby control the transcription of genes. 
Transcription factors perform this function alone or with other proteins in a complex, by 
promoting (as an activator), or blocking (as a repressor) the recruitment of RNA polymerase 
to specific genes. A defining feature of transcription factors is that they contain one or more 
DNA binding domains which attach to specific sequences of DNA adjacent to the genes that 
they regulate [72, 73]. Additional proteins such as coactivators, chromatin remodelers, histone 
acetylases, deacetylases, kinases, and methylases, while also playing crucial roles in gene 
regulation, lack DNA binding domains, and therefore are not classified as transcription 
factors. 
There are approximately 2600 proteins in the human genome that contain DNA-binding 
domains and most of these are presumed to function as transcription factors [74]. Recent work 
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has the shown the figure is closer to 2000[75-77]Therefore approximately 10% of genes in the 
genome code for transcription factors which makes this family the single largest family of 
human proteins. Furthermore genes are often flanked by several binding sites for distinct 
transcription factors and efficient expression of each of these genes requires the cooperative 
action of several different transcription factors. Hence the combinatorial use of a subset of the 
approximately 2000 human transcription factors easily accounts for the unique regulation of 
each gene in the human genome during development [78]. 
Transcription factors have many functions in eukaryotes, an important class of transcription 
factors called general transcription factors (GTFs) are necessary for basal transcription to 
occur. Many of these GTFs don't actually bind DNA but are part of the large transcription pre-
initiation complex that interacts with RNA polymerase directly. The most common GTFs are 
TFIIA, TFIIB, TFIID ,TFIIE, TFIIF, and TFIIH [79]. The pre initiation complex binds to 
promoter regions of DNA upstream to the gene that they regulate. Transcription factors 
differentially regulate the expression of various genes by binding to enhancer regions of DNA 
adjacent to regulated genes. These transcription factors are critical to making sure that genes 
are expressed in the right place at the right time and in the right amount depending on the 
changing requirements of the organism. Many transcription factors in multicellular organisms 
are involved in development [80]. Responding to cues (stimuli), these transcription factors 
turn on/off the transcription of the appropriate genes which in turn allows for changes in cell 
morphology or activities needed for cell fate determination and cellular differentiation. The 
Hox transcription factor family, for example, is important for proper body pattern formation in 
organisms as diverse as fruit flies to humans [81, 82]. Another example is the transcription 
factor encoded by the Sex-determining Region Y (SRY) gene which plays a major role in 
determining gender in humans [83]. 
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Cells can communicate with each other by releasing molecules that produce signaling 
cascades within another receptive cell. If the signal requires up regulation or down regulation 
of genes in the recipient cell, often transcription factors will be downstream in the signaling 
cascade [84]. Estrogen signaling is an example of a fairly short signaling cascade that involves 
the estrogen receptor transcription factor: estrogen is secreted by tissues such as the ovaries 
and placenta, crosses the cell membrane of the recipient cell, and is bound by the estrogen 
receptor in the cell's cytoplasm. The estrogen receptor then goes to the cell's nucleus and binds 
to its DNA binding sites, changing the transcriptional regulation of the associated genes [85]. 
Not only do transcription factors act downstream of signaling cascades related to biological 
stimuli, but they can also be downstream of signaling cascades involved in environmental 
stimuli. Examples include heat shock factor (HSF) which upregulates genes necessary for 
survival at higher temperatures [86], hypoxia inducible factor (HIF) which up regulates genes 
necessary for cell survival in low oxygen environments [87], and sterol regulatory element 
binding protein (SREBP) which helps maintain proper lipid levels in the cell [88]. Many 
transcription factors, especially some that are oncogenes or tumor suppressors, help regulate 
the cell cycle and as such determine how large a cell will get and when it can divide into two 
daughter cells [89, 90]. One example is the Myc oncogene, which has important roles in cell 
growth and apoptosis [91]. 
Thus transcription factors are important components of the cellular machinery which are 
integral to the normal functioning of the cell and the organism. As shown above (section 1.1a) 
many cis-regulatory mutations cause diseases and most of these cis-regulatory elements 
control transcription factors. Thus to understand the full range of actions of theses 




1.9   Scope of this study 
This study aims to use the power of comparative genomics to locate evolutionary conserved 
cis-regulatory element for vertebrate transcription factors that are involved in development. 
Previous studies have shown that developmental control genes generally have enrichment for 
CNEs around them [60, 92-94]. For example, 83% of the CNEs (>70% identity, >100 bp 
alignment length) identified in human – fugu genome wide comparison were located in the 
vicinity of about 120 human developmental transcription factors [60] and 104 of the 290 
human genes associated with CNEs (>70% identity, >80 bp sequence alignment) in a human – 
zebrafish alignment were found to code for transcription factors [66]. In spite of 
overwhelming evidence to the fact that developmental control genes have high numbers of 
CNEs in the vicinity which have been constrained at the sequence level for a long time in 
evolution hence hinting at functionality, there has been limited attempts to exploit this fact to 
systematically look for cis-regulatory elements for highly functionally conserved 
developmental control genes [54, 95, 96]. All of these studies primarily focused on looking at 
the whole genome for functional CNEs, most of them did not look at the CNEs in the context 
of individual genes. Although some studies have compared orthologous gene regions of 
human, rodents, fugu and zebrafish [93, 97, 98], such studies were promoter centric and 
limited as comparison were restricted to sequences flanking the promoter start sites. But by 
nature cis-regulatory elements are distance independent and can be located megabases away 
from the transcription start site. My study takes a “gene-centric” approach to locate and 
validate CNEs as potential enhancers and hence aims to add on to the current state of the art 
and give helpful insight into gene regulation during development 
In my comparative genomics study, I have compared human, mouse and zebrafish genome. 
This allows us compare two closely related (human-mouse) with a phylogentically distant 
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species (zebrafish) for genes which are conserved in function through evolution. This also 
allowed us to test the hypothesis that genes conserved through evolution will have most of its 
regulatory elements constrained at sequence level.  We tested all the CNEs (>60% identity > 
100bp alignment) found up to 1Mb on either side of the gene (including intronic) or in the 
syntenic block around the gene in the three species for 4 developmental control genes. We 
validated them in a functional assay in zebrafish and finally assayed for enhancers by BAC 













Chapter 2: MATERIALS AND METHODS 
2.1   Zebrafish as a model organism 
Zebrafish (Danio rerio) is an attractive model organism to study vertebrate development and 
genetics. Zebrafish are vertebrates and they are more closely related to humans than 
commonly used invertebrate models such as insects and worms (Drosophilia - fruit flies and 
Caenorhabditis elegans - nematodes). Because zebrafish are more closely related to humans, 
they are more likely to be similar to them in many biological traits than a more distantly 
related organism. These biological traits would include genes, developmental processes, 
anatomy, physiology, and behaviour.  
No single model is perfect, but zebrafish have features that make them easy to maintain, 
manipulate, and observe in the lab. They do well in many environments, and their small size, 
their ability to be kept together in large numbers, and the ease with which they can be bred 
makes them a favored model. Breeding and getting eggs from the zebrafish is relatively easy. 
Their eggs are externally fertilized, produced regularly in large numbers, and are non-
adhesive. Their embryos develop rapidly, and are clear throughout their development. Their 
embryos are also smaller than many vertebrate embryos and it is easier to trace the 
development of individual cells.  
Females lay large quantities of eggs. The large number of embryos makes zebrafish a suitable 
organism to do large scale screening and get statistically relevant data in a short time. The 
embryos develop outside the mother's body, so you can have easy access to them. In contrast, 
mouse embryos develop inside the mother (in utero), and you have to kill the mother to get at 
them. This would have to be done at each of the stages of development you want to look at. 
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Once the embryos are extracted from the mother both of them dies so researchers are limited 
by the types of experiments they can do.  
Zebrafish embryos are transparent. This means you can watch development as it happens in 
living embryos. You can see internal organs, such as the brain, heart, blood, muscles, etc. In 
addition, you can monitor the behavior of single cells in live embryos and watch the cells 
divide and through dyes, trace where each cell’s "daughters" go in making up the complete 
organism. It is not possible to achieve this resolution with other systems. The embryos 
develop quickly. They go from a single cell to something that is recognizable as a tiny fish 
within 24 hours whereas mice take 21 days.  
You can physically manipulate the embryos. You can transplant single cells or groups of cells 
into host embryos. This kind of experiment is performed frequently to analyze the behavior of 
cells at different stages, or to ask how mutant cells behave in wildtype embryos. This can give 
us a lot of information about how certain gene products act.   In addition, fertilization of the 
egg can be manipulated so that the embryo contains only maternal genes. This is done by 
exposing the sperm to ultraviolet light which destroys the genes it contains from the male. 
This allows researchers to study recessive mutations since the characteristics and defects are 
inherited from only one parent. 
2.2 Fish Maintenance 
Fish were maintained in the GIS zebrafish facility (IACUC No. 080376) under institutional 
guidelines, according to standard procedures. Crosses were set up in the evening and the 
barrier was lifted in the next morning. After half an hour, the fertilized embryos were 
collected and maintained at 28.5°C in egg water supplemented with methylene blue. 
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2.3 RNA In situ Hybridizations 
DNA clones for making in situ hybridization probes were obtained from the Expressed 
Sequence Tag (EST) clone collection at the Genome Institute of Singapore (GIS) and probe 
preparation was carried out as follows- the cDNA was PCR amplified with primers, forward- 
5`GATGTGCTGCAAGGCGATTAAG3` and reverse 
5`AGCGGATAACAATTTCACACAGG3`, designed on the vector backbone. 400 ng of PCR 
product was mixed with 2µl 10X RNA labeling mix (Roche Diagnostic, USA), 2µl 10x 
transcription buffer (Roche Diagnostic, USA), 1µl RNase inhibitor (Roche Diagnostic, USA), 
1µl RNA polymerase (Roche Diagnostic, USA) and DEPC water to top it up to 20µl. This was 
incubated at 37° C for 4 hours. 2.4µl of 5M EDTA was used to stop the reaction and DEPC 
water was added to top it up to 25µl. 1x isopropanol was added and the mixture stored at -20° C 
for < 20 minutes. The mixture was centrifuged at 14000 rpm for 10 minutes at 4°C in a table top 
centrifuge, the pellet was washed with 70% ethanol and centrifuged again and the pellet re-
suspended in 30ul DEPC water. The concentration of the RNA was checked using a nanodrop 
and gave yields of between 300-600 ng/µl. Whole mount in situ hybridization using digoxigenin 
(DIG) (Roche) labeled RNA probes was performed following [99] and reported below. 
DAY 1- Embryos were dechorionated and fixed in 4% Paraformaldehyde (PFA) for two hours 
at room temperature and dehydrated through grades of methanol. 
DAY 2- Embryos were rehydrated through grades of methanol and post-fixed with 4% PFA 
for 20 minutes at room temperature. The embryos were thoroughly washed with PTW 
(Phosphate buffer saline + 1% Tween 20). This was followed by Proteinase K (10µg/ml) 
treatment for varying length of time depending on the stage of the embryo (1 minute for 24 
hpf, 1 minute 30 second for 48 hpf). The embryos were washed with PTW and fixed with 4% 
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PFA for 20 minutes at room temperature. The embryos were washed for 45 minutes with 
PTW and then rinsed with 1:1 mixture of PTW and hybridization mix, followed by rinsing 
with only hybridization mix and incubation at 68°C for 4 hours. The hybridization mix is then 
replaced by fresh hybridization mix and DIG labeled RNA probe is added to the hybridization 
mix at a final concentration of 1µg/ml and left to hybridize overnight at 68°C in a rocking 
oven. 
DAY 3- The embryos are rinsed and washed with fresh, pre-warmed hybridization mix and 
then washed with 1:1 mixture of hybridization mix:1 X MABT followed by thorough washes 
with MABT at room temperature. The embryos are incubated for one hour in 2% Boehringer 
blocking reagent (BBR) diluted in MABT followed by incubation > 1 hour in 2% BBR and 
20% heat inactivated sheep serum. The embryos were then incubated overnight with 1:5000 
dilution of the alkaline phosphatase-anti-DIG antibody diluted in 2% BBR+ 20% heat 
inactivated sheep serum. 
DAY 4- The embryos are washed in MABT for one hour five times and then minimally 
overnight at 4°C by rolling, rotating or rocking. 
DAY 5- The embryos are washed with alkaline phosphatase buffer (NTMT) for one hour each 
upto three times and then incubated with enough alkaline phosphatase substrate NBT/BCIP in 
the dark for colour development. In situ hybridized embryos were observed using light 






2.4  Conservation tracks at the UCSC genome browser 
The UCSC genome browser generates the pair wise alignments for each species using BlastZ, 
followed by chaining and netting. The pair wise alignments are then multi aligned using 
MultiZ, following the ordering of the species tree. The resulting multiple alignments are then 
assigned conservation scores by phastCons [100], using a tree model with branch lengths 
derived from the ENCODE project multi-species sequence analysis.  
The phastCons program computes conservation scores based on a phylo-HMM, a type of 
probabilistic model that describes both the process of DNA substitution at each site in a 
genome and the way this process changes from one site to the next [101, 102]. PhastCons uses 
a two-state phylo-HMM, with a state for conserved regions and a state for non-conserved 
regions. The value plotted at each site is the posterior probability that the corresponding 
alignment column was generated by the conserved state of the phylo-HMM. These scores 
reflect the phylogeny (including branch lengths) of the species in question, a continuous-time 
Markov model of the nucleotide substitution process, and a tendency for conservation levels 
to be auto correlated along the genome (i.e., to be similar at adjacent sites). Note that, unlike 
many conservation-scoring programs, phastCons does not rely on a sliding window of fixed 
size, so short highly-conserved regions and long moderately conserved regions can both 
obtain high scores. PhastCons currently treats alignment gaps as missing data, which 






2.5  Genome alignments and Conserved Non-coding Elements (CNEs):  
 UCSC genome browser’s (http://genome.ucsc.edu/) zebrafish (Danio rerio) Zv6 genome 
assembly was used as a base genome to align the genome sequences with mouse ( mm8 
assembly) and human (hg18 assembly) for regions around genes of interest. The closest gene 
to the start of each CNE was determined by looking at known gene annotations on the UCSC 
genome browser. The UCSC browser’s conservation track (phastcon conserved elements) was 
used to determine conserved elements (>60% identity, >100 bp length). Transcribed 
sequences in the conserved set were filtered out using known genes, spliced ESTs and mRNA 
annotations (intronic conservation was allowed) [54].  We confined our search for CNEs up to 
1Mb or till wherever there was a break in synteny around the gene of interest between the 
three species.  
2.6 Functional Assays 
             We assayed for enhancer activity in embryos by either co-injecting the candidate enhancer 
element with a minimal promoter-reporter vector in a method previously described [60, 103] 
or by ligating individual CNEs to the reporter construct. This co-injection strategy is an 
efficient and rapid method to assaying enhancer activity in zebrafish. But for all CNEs we 
ligated the CNEs to the reporter construct. Only the BAC fragments for otx1b BAC were co-
injected. 
              In series of control experiments we injected just the reporter construct alone (negative 
control), which showed no EGFP expression or cloned in a 1.4kb Dlx5a/Dlx6a intergenic 
conserved element(positive control) from zebrafish, into the reporter construct, which had 
previously been reported to have enhancer activity in transgenic assay [104]. This intergenic 
conserved element recapitulated the data as reported. (Fig A11) 
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 For preparation of DNA for microinjections, CNEs were PCR amplified from zebrafish 
genomic DNA or bacterial artificial chromosomes (BACs) containing the region of interest 
(50-100bp sequences immediately flanking the core conserved region on either side was 
included in the PCR) (Table 1,2,3,4). DNA was purified using the QIAquick PCR purification 
kit (Qiagen, USA). The minimal vector was constructed by cloning in the EGFP ORF 
(Clontech, USA) under the control of a minimal promoter from the mouse β-globin gene 
(Figure A10). This fragment was cut out of the vector backbone using a SmaI restriction 
enzyme and gel purified using QIAquick gel extraction kit (Qiagen, USA). Element DNA (at 
100-300ng/µl), reporter fragment (50ng/µl) and phenol red (0.1% as tracer) were combined 
and injected into at least 100 1-cell zebrafish embryos produced from natural mating using a 
Pico-Injector (PLI-100 Harvard Instrument, USA). For ligation experiments the PCR 
amplified CNEs were cloned into the multiple cloning site (MCS) of the reporter construct 
(Fig. A10) and the construct was double strand sequenced and the circular vector was injected 
in 1-cell zebrafish embryo. Previous experiments have demonstrated that circular vectors 
worked as well if not better in zebrafish transgenics [105]. We also injected 100 1-cell 
embryos with only the reporter construct alone and also kept 100 un-injected fish as control to 
compare for auto fluorescence. A CNE was scored as a functional enhancer if it expressed 
consistently in the relevant in at least 30% of the embryos at the time point under observation. 
For one of the gene under study (nkx3.2) we also ligated the putative enhancer elements 
upstream of the endogenous nkx3.2 promoter. The nkx3.2 promoter was selected by looking at 
the immediate upstream region of zebrafish Nkx3.2 gene and PCR primers were designed 
spanning 0.5 kb of DNA 5` of the nkx3.2 translation start sites. It was important for the 
ensuing experiments, to ascertain that this fragment of DNA lacked any transcriptional 
activity on its own. We therefore cloned the Nkx3.2 promoter in front of the EGFP gene in the 
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vector. Injection of this construct into zebrafish embryos did not produce any GFP expression, 
confirming that the nkx3.2 promoter is silent in the absence of enhancer elements. Enhancer 
elements were tested both with the endogenous as well the β-globin promoter and subsequent 
assays with showed that the nkx3.2 enhancers showed similar expression irrespective of the 
promoter. Hence for all the other genes under study we only used the β-globin promoter for 
uniformity. 
             The injected embryos were raised in 28.5ºC incubator. The stages of embryos were indicated 
as hpf (hours post-fertilization) or dpf (days post-fertilization) [106]. From 24 hours onward 
the embryos were raised in egg water containing 30 mg of PTU in 1 liter of water. This helps 
to prevent pigmentation and allows better visualization of the EGFP signal. The GFP2 filter of 
stereomicroscope (Leica Microsystems, Germany) was used to observe the EGFP signals in 
transgenic zebrafish. The Leica DFC camera was used to take photographs and was captured 
using the IM50 software from Leica. 
             The embryos were observed at various time points in development (from 6hpf to 3dfp) for 
GFP expression. On basis of the GFP expression a CNE was scored as positive, negative or 
positive but not in “expected” domain of the gene. The domains of expression were annotated 
by referring to the RNA insitu hybridization results for the gene and also by cross referring to 
existing gene expression data at ZFIN (The Zebrafish Model Organism Database). 
        2.7   BAC targeting construct and modification 
 The UCSC genome browser was used to locate BACs containing the gene of interest. The 
BACs were ordered from BACPAC, CHORI (Children’s Hospital Oakland Research 
Institute). A BAC was selected which contained sufficient flanking genomic sequences 
around the gene. This enabled us to retain the regulatory elements in their proper genomic 
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context and hence increase the possibility of capturing the maximum number of distal cis-
regulatory elements present on either side of the gene.  A BAC targeting vector was 
constructed by PCR amplifying a FRT-PGK-gb2-NEO-FRT cassette from a commercially 
available vector (Gene Bridges, GmbH) with the primers, forward -
5`AATTAACCCTCACTAAAGGGC-3` and reverse -5` 
TCTGCGGCCGCTAATACGACTCACTATAGGGC-3` .The gb2 promoter allowed for the 
expression of the kanamycin in the bacterial system. The FRT flank sites allow us to remove 
the selection cassette with FLPe protein if necessary later on. This was cloned into the NotI 
site of a pBlueScript vector SK+ (Stratagene, USA) containing EGFP ORF between its XhoI-
NotI sites. This fragment containing the EGFP ORF and selection cassette was PCR amplified 
with 50bp homology arms on either side of the translational start site of each gene of interest 
and homologous recombination was done using the GeneBridges BAC modification kit (Gene 
Bridges, GmbH) as per the manufacturer’s instructions and described below. 
 The BAC of interest was inoculated in LB medium with appropriate antibiotics at 37°C 
overnight in a shaking incubator. A 30 µl aliquot was inoculated in fresh 1.4 ml media 
containing the same antibiotics the next day for 2-3 hours. The tubes were centrifuged at 
11,000 rpm for 30 seconds in a chilled (2°C) bench top centrifuge. The supernatant was 
discarded and the pellet was resuspended in 1 ml chilled double distilled water and centrifuged 
again for 30 seconds at 11,000 rpm in a chilled centrifuge. This was repeated two more times 
and in the final centrifuge 20-30ul of the supernatant was left behind in the tube. 1µl of the 
Red/ET recombination protein expression plasmid – pSC101-BAD-gbaA (Gene Bridges, 
GmbH) was added to the chilled cell pellet, mixed briefly and kept on ice. 30 µl of this mixture 
was transferred to a chilled electroporation cuvette and electroporated at 1350 V, 10 µF, 600 
Ohms with a 5 millisecond pulse. The electroporated cells were resuspended in 1ml of media 
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without antibiotics and grown at 30°C for 70 minutes (the Red/ET expression plasmid is lost at 
37°C). The cells are then plated in an agar plate containing tetracycline and appropriate 
antibiotics for the BAC. 
In the second stage the colonies from the above plate were picked and inoculated in LB media 
containing tetracycline and appropriate antibiotics for the BAC overnight at 30°C in a shaking 
incubator. The next day a 30 µl aliquot was inoculated in 1.4 ml fresh LB conditioned with the 
same antibiotics and incubated at 30°C till OD 600 reaches to about 0.3. 50 μl 10% L-
arabinose was added to the tubes (giving a final concentration of 0.3%-0.4%). This induced the 
expression of the Red/ET recombination proteins. The bacteria were then incubated at 37 °C 
with shaking for 45 min to 1 hour.  
It is important that cells are incubated at 37 °C, the temperature at which all proteins 
necessary for the subsequent recombination are expressed. There are about 5 copies of this 
temperature-sensitive plasmid per cell, and during one hour there is approximately 1 doubling 
step, meaning any daughter cell will still have on average 2-3 copies left and will also go on 
expressing the recombination proteins. The plasmid is actually lost after electroporation and 
recombination, when cells are incubated at 37 °C over night.  
 Cells were centrifuged for 30 seconds at 11,000 rpm in a cooled bench top centrifuge (at 2 
°C). Supernatant was discarded by quickly tipping out the supernatant twice. The pellet was 
resuspended with 1 ml chilled ddH2O, by pipetting up and down three times to mix the 
suspension. The centrifugation was repeated and the cells resuspended again. The supernatant 
was tipped out once more; 20 to 30 μl was left in the tube with the pellet. Tube was kept on 
ice. 1-2 μl (0.1-0.2 μg) of the PCR product containing the PGK-gb2 Neomycin with 
homology arms were added to the pellet in the Eppendorf tube, and the mixture pipetted into 
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the chilled electroporation cuvette and electroporated at 1350 V, 10 µF, 600 Ohms with a 5 
millisecond pulse.   
 1 ml LB medium without antibiotics was added to the cuvette. Cells were mixed carefully by 
pipetting up and down and pipetted back into the Eppendorf tube. The cultures were incubated 
at 37 °C with shaking for 70 min. Recombination occurs now.  
The cultures were streaked with a loop (100 μl is sufficient) onto LB agar plates containing 
the appropriate antibiotics for the BAC and kanamycin (15 μg/ml). The plates should not 
contain tetracycline; otherwise the Red/ET Recombination protein expression plasmid 
(pSC101-BAD-gbaA) will either persist or the cells will die. Plates were incubated at 37 °C 
overnight. The Red/ET recombination protein expression plasmid (pSC101-BAD-gbaA) will 
disappear at 37 °C. 
 The modified BACs were double strand sequenced at the modified region to ensure mutation 
free transgene insertion at the correct location. The properly modified circular BACs were 
injected into one cell zebrafish embryos produced by natural mating and followed over the 




Figure 1: A schematic of homologous recombination in zebrafish BAC. LHA- left homology arm. 
RHA –right homology arm. NEO- drug selection cassette. RE- regulatory element 
 
2.8   Electrophoretic Mobilty Shift Assays (EMSAs) 
Nuclear proteins were extracted from 24 hpf zebrafish embryos using the NE-PER nuclear 
and cytoplasmic extraction kit (Thermo Scientific, USA). EMSAs were carried out using 
DNA probes modified with 5′ Cy5 labels (Sigma Proligo). The 200 bp non-conserved 
functional element was sub divided into six 40 bp and one 30 bp overlapping fragments 
having a 10 bp overlap. Equimolar amounts of complementary strands were mixed and heated 
to 95°C followed by gradual cooling to ambient temperature over at least 5 h to anneal the 
probes. For binding studies, double-stranded DNA probes at 10 nM were mixed with 10µg of 
nuclear proteins and 500 ng of Poly dI-dC (Sigma) in a buffer containing 40 mM Tris-HCL 
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(pH 8.0), 0.4 mg/ml BSA, 200 µM ZnCl2 , 400 mM KCl, 40% glycerol and 0.4% IGEPAL 
and incubated at 4°C in the dark for one hour. The bound and unbound probes were 
subsequently run on a pre-run 8% 1X TBE polyacrylamide gel for approximately 30 min at 
200 V. The fluorescence was detected using a Typhoon 9140 PhosphorImager (Amersham 
Biosciences). At least three independent experiments for each binding site were performed to 
ascertain binding.  
Mutation studies on the 40 bp fragment (EM4) that showed a shift was carried out by 
sequentially mutating 5 or 10 bases each along the sequence by transversion and carrying out 
EMSA on each mutant probe. 
For supershift experiments, 10 µg of 24 hpf zebrafish nuclear extract was incubated with 
10nM EM4 probe and 1 µg of antibody against the predicted transcription factor, incubated 









Chapter 3: RESULTS FOR FUNCTIONAL ASSAYS  
3.1 nkx3.2  
Bagpipe related homeobox containing genes are members of the ancient NK gene family[107] 
and are highly conserved in sequence and function from Drosophila to humans. It restricts the 
multipotential mesodermal progenitor to a chondroblast lineage and helps in the development 
and evolution of the axial skeleton in mouse and has potential role in human skeletal disorders 
[108-110]. It has also known role in jaw joint formation and patterning [111, 112]. nkx3.2 has 
also been detected in the dorsal and anal fin radials of zebrafish as late as 10dpf and in the distal 
chondrocytes [113]. In zebrafish nkx3.2 expression was detected by RNA insitu in the 
sclerotome and parts of anterior branchial arches (Fig 2A) from about 16hpf to 48 hpf 
3.2 CNEs in and around nkx3.2 
UCSC genome browser’s alignment of sequences near Nkx3.2 in zebrafish  (Fig. 2)revealed 
four conserved elements around the gene matching our criterion, which were named Bx1 to Bx4 
and varied in length from 318 to 990 bp (Table 1). These pieces were co-injected with the 
minimal promoter-reporter construct into one cell zebrafish embryos and observed for 
expression in the domains of expression of nkx3.2 in zebrafish at different time points. Only one 
element Bx1 (Fig A1) drove EGFP expression which was detected along the anterio-posterior 
axis in the region of the emerging sclerotome/myotome (60% of the injected embryos) (Fig 3B). 
This partially recapitulated the RNA in situ data for the gene. There was no EGFP expression 
from the remaining CNEs at the developmental time points under observation. For this gene we 
also cloned all the 4 enhancer elements upstream of the promoter in the same order as they are 
found in the genome and this mega construct was also tested. But we did not see any significant 
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increase in expression level or domain from all the four enhancers versus only the single 
functional CNE (data not shown). We also tested the efficacy of co-injection over ligation with 
the CNEs for nkx3.2. All the CNEs were also ligated to the minimal reporter construct as 
opposed to co-injection. Again only one element bx1 could drive EGFP either when co-injected 
with the reporter construct or ligated to it. Thus only 25% of the CNEs are functional at all time 
points under observation. 
 
Figure 2: UCSC Genome browser (Zv6 assembly) window showing zebrafish nkx3.2(red box) gene 












Figure 3: nkx3.2 CNEs and modified BAC 
(A) nkx3.2 RNA in situ at 48 hpf. (B) bx 1 at 24 hpf showing expression along 
sclerotome/myotome.  Modified BAC at 24 hpf (C) and 48 hpf (D) along the same domain as 
the endogenous gene 
 
 
Table 1: All the CNEs around the gene nkx3.2 which were tested individually with a minimal promoter 




CNE Size (in base pairs) Genomic locus in zebrafish 
bx1 318 chr14:1,308,453-1,308,770 
bx2 860 chr14:1,289,165-1,290,024 
bx3 158 chr14:1,297,231-1,297,388 





pax9 is a member of the paired box (PAX) family of transcription factors. Members of this gene 
family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. 
The paired domain consisting of 125–128 amino acids, encoded by the paired box, was named 
after the Drosophila pair-rule segmentation gene paired (prd) where it was first identified. There 
are nine known Pax genes in mouse (Pax1 to Pax9) and also humans (PAX1 to PAX9). Except 
Pax4 all other Pax genes also are present in zebrafish. The Pax genes show tightly regulated 
spatio-temporal expression during development. Pax9 along with Pax1 has  been shown to be 
required for the chondrogenic differentiation of sclerotomal cells [114]  and is known to regulate 
vertebral column development [115] and also been shown to express in somites, pharyngeal 
pouches, mesenchyme  and involved in craniofacial, tooth, and limb development [116]. Mutant 
analyses of mouse Pax1 and Pax9 revealed that these two paralogs play divergent, but partially 
redundant, roles in patterning the vertebral column. Pax1 can almost fully compensate for the 
absence of Pax9, whereas Pax9 function incompletely rescues vertebral column formation in 
Pax1-deficient mice [116, 117]. In teleost fish there is evidence to suggest that pax9 is 
indispensible for the development of the sclerotome and the neural arch [118]. Zebrafish pax9 
expression is initiated at the end of the segmentation period in mesenchymal sclerotome cells on 
both sides of the notochord similarly to the corresponding mouse and chick genes. Two 
transcripts, pax9a and -b, are generated by alternative splicing. The gene contains 4 exons with 
exon 3 being included in the pax9a transcript and spliced out in the pax9b transcript.[119] 
The Pax9a and -b proteins are identical for 212 amino acids from the N terminus but contain 
distinct C-terminal regions of 131 and 58 amino acids, respectively. The paired domain of Pax9 
displayed a binding site specificity distinct from Pax6 but similar to Pax1and -2. Both Pax9a and 
-b activated a promoter containing a paired domain binding site. Comparisons of the two 
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zebrafish protein sequences to the published murine Pax9 cDNA sequence [120] clearly show 
Pax9a to represent the zebrafish homologue. 
Our RNA in situ hybridization detects expression of pax9 in sclerotome and part of branchial 
arches at 24hpf but at 48hpf the expression in the sclerotome is rather weak and restricted to the 
posterior end and expression is also detected in the branchial arch (Fig 5A)  
3.4  CNEs in and around Pax9 
Alignment of the sequences around pax9 (Fig 4)revealed 11 conserved elements matching our 
criteria ranging in size from 311 bp to 1.2 kb (Table 2) until there was a synteny break in one or 
both species which were used in the alignment. Six of these pieces were at the 5 prime end of the 
gene while five were from the 3 prime end, with the furthest being 178 kb away. Three out of 
these CNEs drove EGFP expression along the A-P axis as marked by the sclerotome when co-
injected with the minimal promoter-reporter construct. All the three CNEs drove expression of 
EGFP along the presumptive sclerotome at different time points in development. Elements Px2 
(Fig 5B,A2) and Px4 (Fig 5C,A3) which were 23 and 27 kb away from the gene on the 5` end 
drove expression in the sclerotome/myotome at 24 hpf, whereas Px7(Fig A7) which was 17 kb 
away from the gene at the 3` end drove EGFP expression in the same domain at 48hpf . This data 
was interesting in the light of similar observations being made in Drosophila for having multiple 
enhancer for one gene all driving expression in the same tissue [121] and raises interesting 
questions regarding the evolution of cis-regulatory DNA. Thus only 27% of the CNEs were 





Figure 4: UCSC Genome browser (Zv6 assembly) window showing zebrafish pax9 (red box) gene its synteny 






Figure 5:  pax9 CNEs and modified BAC 
(A) pax9 RNA in situ at 36 hpf. (B) Functional CNE Px2 at 36 hpf in sclerotome/ myotome (C) 
Functional CNE Px4 at 36 hpf in sclerotome/ myotome (white arrows) (D) Modified BAC at 36hpf. 












Table 2: All the CNEs around the gene pax9 which were tested individually with a minimal promoter 






CNE Size (in base pairs) Genomic locus in zebrafish 
px1 312 chr17:47,948,887- 47,949,198 
px2 300 chr17:47,958,914-47,959,213 
px3 518 chr17:47,960,285-47,960,802 
px4 587 chr17:47,962,414-47,963,000 
px5 618 chr17:47,963,830-47,964,447 
px6 404 chr17:47,968,026-47,968,429 
px7 942 chr17:47,910,698-47,911,639 
px8 311 chr17:47,797,426-47,797,736 
px9 554 chr17:47,767,357-47,767,910 
px10 1244 chr17:47,756,199-47,757,442 




Orthodenticle homolog 1 is a vertebrate homolog of the Drosophila orthodenticle and encodes a 
member of the bicoid sub-family of homeodomain containing transcription factors. Otx1 along 
with Otx2 has been implicated in the regional patterning of the rostral head and both are 
synergistic in function in certain domains of the brain[122]. In E9-E10 day mouse embryo, its 
expression domain dorsally is comprised of a continuous region including part of the 
telencephalon, the diencephalon and the mesencephalon. The posterior boundary of this domain 
coincides with that of the mesencephalon. Ventrally, the Otx1b expression domain includes 
contiguous regions of both diencephalon and mesencephalon with sharp anterior and posterior 
boundaries [123]. Mouse Otx1 homozygous mutants shows subtle skull anomalies [122].The 
Otx1 gene has been strongly associated with the formation of the otic vesicle in gnathostomes 
starting with the teleost fish and hence helping in transition from the jawless vertebrates to a 
more gnathostome characteristics [124] and also in determining cerebellar cell identities in 
zebrafish [125]. Our RNA in situ hybridization detected otx1b expression in the neural plate as 
early as early as 6 hpf. At 24hpf the gene was detected in the diencephalon, mid brain, otic 
vesicle and retina. We assayed for gene expression patterns till 48hpf  up to which it continued 
to be strongly expressed in the neural plate at 9 hpf (Fig 7A) and fore and mid brain at 24 hpf. 
(Fig 7B) 
3.6  CNEs in and around Otx1b 
Genome alignment revealed16 CNEs in the syntenic block around otx1b (Table 3) (Fig 6). All 
the CNEs were present on the 5` end of the gene with the farthest being 172kb away. There was 
no synteny at the 3` end of the gene with mouse and human genomes. These CNEs were co-
injected individually with a minimal reporter construct. Ox4 (Fig A7) strongly recapitulated the 
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gene expression at 6 hpf at the neural plate (Fig. 7C) Both Ox2 (Fig A5) and Ox3 (Fig A6) 
which are adjacent to each other and about 8-10 kb away from the gene drove EGFP expression 
in the forebrain Ox2 at 36 hpf (Fig 7D)and Ox3 at 3 dpf (Fig 7E). We did not detect any EGFP 
expression from the other CNEs when they were assayed individually with the reporter 




Figure 6: UCSC Genome browser (Zv6 assembly) window showing zebrafish otx1b (red box) gene its synteny 













Figure 7 : otx1b CNEs and modified BAC 
(A) otx1b RNA in situ at 9 hpf and (B) 24 hpf. (C) Functional CNE Ox4 at 9 hpf expressing in 
the neural plate.(D) Functional CNE Ox2 at 48 hpf expressing in the fore brain. (E) Functional 
CNE Ox3 at 3dpf. (F) Modified BAC at 48 hpf showing expression in the domains of 







CNE Size (in base pairs) Genomic locus in zebrafish 
ox1 240 chr17:20,346,160-20,346,519 
ox2 627 chr17:20,352,401-20,353,027 
ox3 529 chr17:20,353,609-20,354,138 
ox4 1045 chr17:20,368,650-20,369,694 
ox5 1397 chr17:20,374,611-20,376,005 
ox6 440 chr17:20,376,073-20,376,512 
ox7 728 chr17:20,382,862-20,383,589 
ox8 464 chr17:20,389,349-20,389,812 
ox9 603 chr17:20,397,827-20,398,429 
ox10 312 chr17:20,420,693-20,421,004 
ox11 995 chr17:20,422,590-20,423,584 
ox12 826 chr17:20,429,817- 20,430,642 
0x13 503 chr17:20,431,325- 20,431,827 
ox14 540 chr17:20,486,395-20,486,934 
ox15 611 chr17:20,494,889- 20,495,499 
ox16 995 chr17:20,517,231-20,518,225 
 
Table 3: All the CNEs around the gene otx1b which were tested individually with a minimal promoter reporter 







3.7  foxa2 
Foxa2 is a member of the forkhead transcription factor family and is specifically expressed in 
the visceral endoderm, anterior definitive endoderm, node, notochord and floorplate of the 
mouse  [126-128]. Mouse Foxa2 mutants die shortly after gastrulation due to patterning and 
morphogenetic defects [129, 130]. Foxa2 also has a critical function in the extraembryonic 
visceral endoderm during gastrulation to elongate the primitive streak [131]. Additionally, 
Foxa2 establishes competence in the foregut endoderm and is required for the normal 
development of the foregut derived organs such as liver, lung, and pancreas [132, 133].In 
zebrafish it has been shown that though foxa2 is not required for the induction of the floorplate, 
it is required for its further differentiation and for induction and/or patterning of several distinct 
cell types in the ventral CNS.[134].Our RNA in situ hybridization detected expression of foxa2 
in the fore brain (fig 9A) and the anterior/ pharyngeal endoderm at 48 hpf (Fig 9B).  
3.8 CNES in and around foxa2 
Using our criteria, we located nine CNEs around foxa2, all of which were located at the 3` end 
of the gene, the closest being 2kb away and the farthest being 60kb away and ranging in size 
from 425bp to 1220bp.(Table 4) (Fig 8). All these CNEs were individually ligated with the 
reporter construct and we visualized the injected embryos at different time points in 
development. Two of the CNEs recapitulated expression of Foxa2 partially in the fore brain 
(Fx2) (Fig 9C, A8) and pharyngeal endoderm (Fx 6)(Fig 9D, A9). There was no detectable 
expression of EGFP from the other CNEs individually at the time points under observation. So 






Figure 8: UCSC Genome browser (Zv6 assembly) window showing zebrafish foxa2 (red box) gene its 


















   
   Figure 9: foxa2 CNEs and modified BAC 
(A) Section in situ hybridization for foxa2 at 24 hpf showing expression at the forebrain and 
(B) pharyngeal endoderm (black arrow). (C) Functional CNE Fx2 expression at 24 hpf in the 
forebrain. (D) Functional CNE Fx6 expression in pharyngeal endoderm at 24 hpf (white 













Table 4: All the CNEs around the gene foxa2 which were tested individually with a minimal promoter reporter 








CNE Size (in base pairs) Genomic locus in zebrafish 
fx1 1002 chr17:55,895,918-55,896,919 
fx2 449 chr17:55,892,393-55,892,84 
fx3 425 chr17:55,889,244-55,889,668 
fx4 779 chr17:55,885,208-55,885,986 
fx5 1220 chr17:55,870,353-55,871,572 
fx6 769 chr17:55,867,708-55,868,535 
fx7 602 chr17:55,925,878-55,926,479 
fx8 651 chr17:55,918,846-55,919,496 
fx9 489 chr17:55,908,053-55,908,541 
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Chapter 4: BAC MODIFICATION AND TRANSGENICS 
Many conventional in vivo transgenic studies have clearly demonstrated the important concept 
of separable regulatory elements controlling spatiotemporal patterns of gene expression. For 
example, in its native genomic context the expression of the endogenous SM22 gene occurs in 
essentially all smooth muscle cell lineages .When taken out of its normal genomic context, 
however, the SM22 proximal promoter is active primarily in arterial smooth muscle cells with 
little or no activity in such smooth muscle-rich tissues as stomach, uterus, and bladder, 
indicating elements controlling expression of SM22 in these tissues reside outside of the region 
analyzed [135]. When a single regulatory element (CArG box) is mutated, virtually complete 
loss in reporter gene activity is observed, suggesting a critical function for the CArG box in 
mediating SM22 promoter activity in arterial smooth muscle. In contrast, some in vitro 
documented promoter/enhancers display little or no activity when cloned in a conventional lacZ 
plasmid for transgenic mouse studies [136]. These few examples imply that proper 
spatiotemporal expression of a gene requires modular cis-regulatory modules (CRMs) that may 
reside remotely from the core promoter region. One important innovation of the human genome 
project was the development of artificial chromosomes that are large capacity cloning vectors 
harboring hundreds of kilobases of genomic DNA. Such vectors offer a powerful means of 
capturing all CRMs and their regulatory elements controlling complete spatiotemporal 
expression of a gene, thus avoiding the incomplete activity profiles observed with most 
plasmid-based transgenic constructs [137]. Distal regulatory elements within CRMs include not 
only enhancers but also silencers and an array of so-called boundary elements (e.g. insulators 
and locus control regions) that establish important points of transcriptional control through the 
establishment of either transcriptional activation or repression complexes [138].  
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Bacterial artificial chromosomes or BACs are such specialized plasmids which can be used to 
clone in large DNA inserts which range in size from 150-300 kb. Large chunks of contiguous 
genomic sequences have been cloned into BAC vectors and have been used for sequencing of 
various genomes. Hence BACs are useful tools to modify a genomic region of interest and study 
a gene and its regulatory elements in its genomic context by introducing a reporter construct 
into the vector backbone of BACs using homologous recombination in E. coli. When assayed in 
transgenic animal, classical enhancers present in the genomic insert of any BAC should be able 
to stimulate the gene promoter and drive transcription of the reporter gene, yielding an in vivo 
readout of any enhancer activity harbored within a particular BAC. Hence by comparing the 
expression of the reporter to the expression of the endogenous gene allows for the determination 
of the regulatory elements for the gene that are present in the genomic region cloned in the 
BAC. BACs and has been successfully used to validate cis-regulatory elements for numerous 
genes in mouse [139, 140] and in certain cases multiple overlapping BACs have been used to 
locate all the regulatory elements of a gene [141] . BAC modification has also been employed 
for zebrafish genes [142, 143], but not as extensively, to locate and validate cis-regulatory, 
elements as in mouse. These powerful approaches do have limitations in that they often employ 
lacZ as a reporter for the facile detection of enhancer activity and/or the removal of the 
enhancer from its native genomic context. In the latter instance, it is possible that CRM activity 
may be associated with another gene that could lie remote from the region under study and have 
nothing to do with the expression of the primary interest gene. In this context, a enhancer 
controlling sonic hedgehog (Shh) expression is found nearly 1 megabase away from its 
promoter region in an intron of a gene (LMBR1) 6 genetic loci removed from Shh [144]. 
Another limitation for assaying an out of genomic context enhancer is they may adapt spurious 
activities based on the close proximity to sequences that are ordinarily remote from the 
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enhancer site. There is growing support for chromosomal looping models of gene transcription 
wherein distal enhancers adapt specialized structures involving protein-protein contacts that 
establish multiple levels of control for transcription, the spatial orientation of the transcribed 
gene, and its post-transcriptional processing [145]. Such structures may also confer repressive 
effects on adjacent genes, the expression of which may be unnecessary in certain contexts. 
Removing distal enhancers from their native genomic context could alter these and other 
important contacts, thus yielding inaccurate activities. On the other hand, small genes (less 
than100 kb) contained in a single artificial chromosome are amenable to systematic analysis of 
putative enhancers by artificial chromosome modifications. Notwithstanding the above 
limitations, there have been great strides in defining distal enhancers driving tissue-specific 
expression of a growing number of genes, thus expanding our appreciation of the complexities 
of gene expression control and providing a foundation for further functional analyses 
We modified the zebrafish BACs containing the genes of interest using Red/ET mediated 
homologous recombination [146] to insert an EGFP open reading frame before the translational 
start site, thus enabling us to characterize a large region genomic DNA around the gene of 









4.1  Results for BAC modification  
nkx3.2 
A BAC (CH73-353E16) containing the zebrafish nkx3.2 gene was indentified from the UCSC 
genome browser and modified by inserting the EGFP ORF and a selection cassette near the 
translational start site of the gene as described. This ensured that the all the cis-regulatory 
elements in the 186 kb genomic region around nkx3.2 which was cloned into the BAC was 
captured in the assay. This modified BAC was sequenced and injected into one cell zebrafish 
embryos and the embryos were followed over its development to detect EGFP in domains of 
expression of nkx3.2. 70% of the embryos gave distinct expression along the anterio-posterior 
axis as marked by sclerotome, at 24 and 48 hpf (fig 3C, 3D), which correlated closely with the 
Nkx3.2 expression as detected by the RNA in situ. We were however unable to detect any EGFP 
expression in the second branchial arch, which showed up as a domain of expression in our 
RNA in situ studies. This led us to conclude that the regulatory elements for this domain lay 
outside the 186kb genomic DNA present in the BAC. 
 pax9 
A zebrafish BAC (CH211-62I6) containing 188 Kb of genomic DNA flanking pax9 was 
modified with EGFP and injected into one cell zebrafish embryo and followed over 
development. The modified BAC recapitulated the gene expression data in the sclerotome/ 
myotome at 24 to 48 hpf. 36% of the embryos at 24 hpf and 45% of the embryos at36 hpf (Fig 
5D) reproduced this expression pattern consistently. We did not detect any EGFP expression in 





The BAC (CH73-220O18) containing the otx1b gene was modified with a reporter and was 
injected into the one cell fertilized zebrafish embryos as previously described. The EGFP 
expression could be detected as early as 6 hpf in the neural plate (data not shown). An 
individual CNE also drove reporter gene expression in the same tissue at the same time point 
and was present in the genomic region cloned in the BAC under testing (Fig 7C). The injected 
embryos also showed EGFP expression in the fore and mid brain at 24 hpf (46% of the 
embryos) and 36-38 hpf (40% of the embryos) (Fig 7F), which overlapped with the endogenous 
gene expressions at the time point as observed by RNA in situ. We detected a much more 
extensive expression domain most of which were not ectopic for the BAC as compared to the 
individual CNEs (Fig 7F), thus leading us to believe that there exist more regulatory elements in 
that genomic region than detected by sequence level constrain. 
 foxa2 
The BAC (CH211-38M14) containing 180Kb of genomic insert in and around zebrafish foxa2 
was modified and injected into single cell zebrafish embryos. The BAC partially recapitulated 
the endogenous gene expression particularly at the rostral end of the embryo at 24 hpf and 48 







4.2 BAC DISSECTION TO DETECT NON-CONSERVED ENHANCERS 
The inability of most of the CNEs to drive EGFP expression coupled with the fact that the 
modified BAC for certain genes had a more extensive expression pattern than recapitulated by 
the CNEs alone led us to hypothesize that that even for highly functionally conserved genes 
there existed regulatory elements which were not constrained at the sequence level. To detect 
such non-conserved enhancers we employed the traditional method of BAC dissection. We 
selected the otx1b BAC for these experiments as the modified BAC for this gene had shown a 
robust spatio-temporal expression, recapitulating substantial domains of expression of the 
endogenous gene (Figure 7F). The BAC was digested with the restriction enzyme XbaI, which 
generated 22 fragments ranging from 48 bp to 27 kb in size (Figure 10A). The fragments were 
individually ligated to the minimal reporter construct and injected into 1- cell zebrafish embryo. 
Three fragments gave EGFP expression in the fore and/or mid brain of the zebrafish embryo at 
24 and 48 hours. Two of the positive fragments contained a functional CNE in them. The third 
fragment, a 6.4 kb piece from the 3′ end (chr17:20,307,773-20,314,262) of zebrafish otx1b gene 
mapped to a large region which included introns and exons of a predicted gene (Ensembl 
Transcript: ENSDART00000090374) (Figure 11A). Though this element was functional in our 
assay (Figure 10F), the fact it mapped to such a large region which included exons led us to 
believe that the core element might be smaller. This 6.4 kb (NC) regulatory element was further 
reduced into five overlapping 1050 bp and one 1500 bp fragment by PCR (Figure 10B). The 
overlapping PCR fragments ensured we did not have abrupt breakpoints in the DNA fragments. 
These six fragments (NC1-NC6) were individually tested by co-injection with the minimal 
reporter construct into zebrafish embryos and one (NC2) of the 1050 bp fragments 
(chr17:20,312,333-20,313,342) partially recapitulated the expression domain in the forebrain of 
the bigger 6.4 kb fragment at 24 and 48 hpf (Figure 10G) There was no expression from the 
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other 5 fragments. NC2 showed only partial conservation to the tetraodon genome (figure 11B). 
NC2 was further reduced to five (NC2A-NC2E) 210 bp fragments by doing overlapping PCRs 
and each piece was individually injected with a reporter construct. Fragment NC2C 
(chr17:20,312,743-20,312,952) on its own could drive expression of EGFP reporter in a subset 
of the expression domain of NC2 in the forebrain (Figure 10H), which was a subset of the 
expression domain of the 6.4 kb fragment in the forebrain. Interestingly the NC2C 210 bp 
fragment had no conservation with any species in the genome alignment (Figure 11C). Thus we 
concluded that this piece was the zebrafish specific enhancer for otx1b as it could drive 
expression in the forebrain which is a domain of expression for the gene. We also observed that 
reducing the size of the DNA resulted in a slight reduction both in the domain of expression as 
well as the level of expression in the embryo. One possible reason for this reduction in 
expression domain was that, although the small 210 bp fragment contained most of the 
transcription factor binding sites essential for its function, it was missing some other binding 
sites which were in the neighboring fragments and the extensive expression domain as seen by 
the 6.4 kb fragment is result of the synergistic activity of multiple transcription factors 






 Figure 10: BAC dissection to detect non-conserved enhancer 
(A) The Otx1b 111 kb BAC showing the gene and the 6.4 kb non-conserved functional 
element and the CNEs present. The blue lines indicate the XbaI restriction sites. The plus sign 
in parenthesis indicates functional CNEs. (B) Six overlapping PCR fragments covering the 6.4 
kb fragment. (C) Five overlapping PCR fragments covering the 1050 NC2 functional 
fragment (D) the seven Cy5 labeled probes designed on the functional NC2C fragment. 
Transgenic assay with the whole BAC (E), 6.4 kb fragment (F), NC2 (1050 bp) fragment (G) 














                                                                                                                                                                                         
 
                                                
                                                                                                                                                  
                                                                      
                                                             
 
                                                             




                                                                    
 
   Fig 11A: An UCSC genome browser snapshot of 6.4 kb non conserved enhancer showing its location 
mapping to the predicted gene next to Otx1b. 
 
Fig 11B: An UCSC genome browser snapshot of Fragment NC2 showing partial conservation to the tetradon 
genome 
 
Fig 11C:  An UCSC genome browser snapshot of Fragment NC2C showing no significant conservation to any 
of the aligned genomes. 
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Chapter 5: BIOCHEMISTRY AND TRANSGENICS TO 
DETERMINE TRANSCRIPTION FACTOR BINDING 
SITE   
Biochemistry based assays have been successfully used in the past to detect transcription 
factor binding sites as well as a transcription factor bound to an enhancer [147-149]. Though 
the method is in vitro and at times might not reflect what actually happens in vivo, but if 
coupled with transgenic experiments can be a powerful tool to both locate and get a deeper 
understanding of enhancer functions.  
A mobility shift assay (EMSA) is electrophoretic separation of a protein-DNA mixture on a 
polyacrylamide for a short period. The speed at which different molecules (and combinations 
thereof) move through the gel is determined by their size and charge, and to a lesser extent, 
their shape. The control lane (DNA probe without protein present) will contain a single band 
corresponding to the unbound DNA or RNA fragment. However, assuming that the protein is 
capable of binding to the fragment, the lane with protein present will contain another band 
that represents the larger, less mobile complex of nucleic acid probe bound to protein which is 
'shifted' up on the gel (since it has moved more slowly). 
Under the correct experimental conditions, the interaction between the DNA and protein is 
stabilized and the ratio of bound to unbound nucleic acid on the gel reflects the fraction of free 
and bound probe molecules as the binding reaction enters the gel. This stability is in part due 
to the low ionic strength of the buffer, but also due to a "caging effect", in that the protein, 
surrounded by the gel matrix, is unable to diffuse away from the probe before. If the starting 
concentrations of protein and probe are known, the affinity of the protein for the nucleic acid 
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sequence may be determined. If the protein concentration is not known, it can be determined 
by increasing the concentration of DNA probe until further increments do not increase the 
fraction of protein bound. By comparison with a set of standard dilutions of free probe run on 
the same gel, the number of moles of protein can be calculated.  
An antibody that recognizes the protein can be added to this mixture to create an even larger 
complex with a greater shift. This method is referred to as a supershift assay, and is used to 
unambiguously identify a protein present in the protein-nucleic acid complex. 
Often, an extra lane is run with a competitor oligonucleotide to determine the most favorable 
binding sequence for the binding protein. The use of different oligonucleotides of defined 
sequence allows the identification of the precise binding site by competition. Variants of the 
competition assay are useful for measuring the specificity of binding and for measurement of 
association and dissociation kinetics. 
5.1 Results for EMSA on non conserved enhancer 
Seven overlapping Cy5 labeled DNA probes were designed to span the 210 bp Otx1b non 
conserved enhancer (NC2C). The probes were incubated with nuclear extract from 24 hpf 
zebrafish embryos and run on a native gel (EMSAs). Two out of the seven fragments showed a 
distinct shift indicating that they contained sites for transcription factor binding (Fig 12A). Both 
of these fragments were co-injected with the EGFP reporter construct into 1- cell zebrafish 
embryos. One of the fragments (EM4) could drive EGFP expression to the rostral portion of the 
brain, recapitulating a subset of the expression domain of the bigger 200 bp fragment (Fig 12D). 
The other fragment which bound protein in vitro did not show any activity in vivo. 
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We went ahead and made tiling 5 bp mutations (nucleotide transversions i.e. 
Purine→Pyramidine) along the 40 bp (EM4) region to narrow down the binding site (Table 
A7). Mutations in nucleotide 21 to 25 completely abrogated binding of the protein with 
weakened binding observed for mutations in nucleotides 26-30 (Fig 12B). Injection of the 
EGFP reporter construct harboring the mutant 5 bp binding sites independently in the zebrafish 
showed weakened EGFP expression but not complete loss of activity (Fig 12E, 12F). This led 
us to believe that the nucleotide 21-30 together harbored the functional site in the enhancer. We 
went ahead and designed mutant probes for the whole 10bp (21-30 nucleotides) region (Table 
A8) and EMSA and transgenic assays showed a complete abrogation of binding and a complete 
loss of EGFP expression in the zebrafish embryos (Fig 12C, 12G). This gave conclusive proof 
that the actual binding site and the core functional domain of the non conserved enhancer lay 
within these 10 nucleotides. 
5.2 Enhancer Binding Transcription Factor 
We used the TRANSFAC database ( www.gene-regulation.com/index.html) to find potential 
transcription factors (TFs) that could bind to the 10bp sequence in our non-conserved enhancer. 
By using a criterion of entire matrix similarity > 0.75 we came up with a list of 3 putative 
transcription factors that could bind the sequence: Foxa1, Pbx2, and Lef1 (Fig 13A). We 
performed supershift assays with antibodies against each potential TF and saw a supershift 
uniquely with the Foxa1 antibody (Fig 13B).  Thus our data clearly indicates that zebrafish 









Fig12:  EMSAs to detect core binding motif 
(A) Electrophoretic Mobility Shift Assays (EMSA) with 7 overlapping probes spanning the 200 bp 
non conserved enhancer. Arrows indicate the two probes which bound protein. (B) EMSAs with 5 bp 
sliding mutant probes. The star indicates the probe 5 which did not show binding and the subsequent 
probe 6 showed weak binding. (C) EMSA with 10bp mutation probes. Mutations in nucleotides 21-30 
(M21-30) leads to complete abrogation of binding. Transgenic assays with wild type 40 bp probe 







Fig 13: Elucidation of transcription factor binding to the enhancer 
(A) Table showing TRANSFAC scores for putative transcription factors binding to nucleotides 21-30. 





Chapter 6: DISCUSSION    
In recent years non-coding DNA has attracted lot of attention [100, 150, 151] mainly due to 
the realization that large fractions of DNA in  human and other genomes does not comprise of 
protein coding exons but other sequences, the functions of which remain elusive. But one of 
the known functions of these DNA sequences has been its regulatory role in either activating 
or suppressing the transcription of a target gene. The idea that animal development is 
regulated by cis-regulatory DNA elements is well established and has been elegantly 
described in invertebrates[95, 152-157]. The identification and characterization of such cis-
regulatory regions within the non-coding region of vertebrate genomes remains a challenge 
for the post genomics era. These elements are thought to consist of clustered target sites for a 
number of transcription factors and collectively form the genomic instructions for 
developmental gene regulatory networks. Any approach to elucidate such networks 
necessitates the discovery of all constituent cis-regulatory elements and their genomic 
locations. Earlier such a task was difficult owing to lack of knowledge of both the complete 
genome sequence as well as the syntax of regulatory elements. The completion of a number of 
vertebrate genome sequences, as well as the concurrent development of genomic alignment, 
visualization, and analytical bioinformatics tools [158], has made large genomic comparisons 
not only possible but an increasingly popular approach for the discovery of putative cis-
regulatory elements. 
A big step forward in the identification of cis-regulatory elements was the discovery that these 
regions can be conserved in vertebrate genomes. For example, 1% of the human non coding 
genome is at least 70% conserved in the mouse genome over a region of 100 bp or longer 
[159-162]. A number of these sequences were shown to be transcriptional regulatory regions. 
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However, other functions such as chromatin attachment sites, miRNA genes or splice 
regulatory regions may also reside in such highly conserved non-coding sequences [55, 94, 
163-165]. Curiously, these highly conserved cis-regulatory regions are preferentially linked to 
developmental regulatory genes such as transcription factors and certain cell communication 
signals [60, 92, 166]. It is unclear why in particular the regulatory regions of transcription 
factors and developmental regulators would need to be conserved so strongly. It is believed 
that regulatory regions of other genes have rearranged their transcription factor binding sites 
within individual modules so much that search algorithms cannot recognize them. In a recent 
paper, it was suggested that conserved regulatory modules might be found in genes other than 
transcription factors and developmental regulators more frequently, if one included the 
possibility that regulatory modules were rearranged within the loci [96]. Given the importance 
of comparative studies between lower and higher vertebrates as a tool to unravel the cis-
regulatory architecture of vertebrate genomes, it is of importance to understand the evolution 
of cis-regulatory elements within the vertebrate lineage. Potentially, one can distinguish three 
different modes of evolution of cis-regulatory regions. Cis-regulatory regions could arise de 
novo by spontaneous accumulation of mutations within a range of a few hundred base pairs, 
thereby creating a functional cluster of transcription factors. The second scenario assumes that 
existing cis-regulatory modules are modified by mutation. In that way, novel patterns of 
expression are generated. Cis-regulatory modules could either lose transcription factor binding 
sites or sequence changes could generate new transcription factor binding sites within an 
existing cluster. The third scenario the evolutionary changes do not occur in the cis-regulatory 
module but rather changes in the expression patterns of the interacting transcription factors 
cause activation of an enhancer in a new cell type, in which the enhancer was previously 
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silent. In this case, one has to assume that the cis-regulatory elements controlling the 
expression of the transcription factors were modified during evolution [167]. 
6.1 “Conserved” non coding elements 
The discovery that potentially many cis-regulatory elements are conserved across the 
vertebrate lineage led to the hypothesis that sequence level constraints over long evolutionary 
distances would be a strong indicator of the functional role of a DNA element. Initial 
functional validations also seem to confirm the hypothesis when a substantial number of such 
elements which were conserved across human – mouse alone or human-mouse-teleost fish 
were functional as enhancers in reporter assays. This was particularly true also for genes 
which were tightly clustered in a syntenic block through evolution, a primary example being 
the Hox cluster.[95] 
Though such large scale alignment studies looking at CNEs in the whole genome was 
laudable and provided an early roadmap to the architecture of the genome as a whole, it did 
not really address the question of trying to figure the best possible way to look at all the 
regulatory elements of a particular gene at various time points in development. Dissecting out 
the regulatory elements of individual genes is critical as it is the first step towards elucidating 
and understanding the complete gene regulatory network. It also allows for a comprehensive 
gene expression profile and helps to match a domain of expression of a particular gene with 
its regulatory element. 
Our study here focused on four developmental control genes that are ancient in origin and 
conserved in evolution. This allowed us to ask three very important questions regarding the 
nature and role of these conserved elements- firstly, are all the conserved elements found in 
the syntenic region around a gene functional? Secondly can we find all the enhancers for a 
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particular gene by looking only at the CNEs? And thirdly, if not where are the other 
regulatory elements for a particular gene?   
6.2 Are all CNEs developmental enhancers? 
The CNEs selected for our study were selected based on a stringent criteria of > 60% 
sequence identity and >100bp in length across three phylogentically distant species (human, 
mouse, zebrafish). As the teleost fishes and mammals last shared a common ancestor about 
450 million years ago, predating the emergence of the majority of all extant vertebrates, it 
strongly implied that any non coding sequences conserved between these two groups are 
likely to be fundamental to vertebrate life and hence functional. But our results clearly 
indicate that only a fraction of the CNEs found in the vicinity of the highly functionally 
conserved developmental transcription factors are actually functional as enhancers. The 
design of our study has also allowed us to address two major arguments which have been put 
forward before to explain the absence of functionality in these CNEs in human-mouse 
comparative studies. By being able to look at potentially all developmental time points we had 
a advantage over most of the studies where the functional testing was done in mouse and was 
restricted to one time point in development [54]. Thus by looking at all major time points in 
development we can conclude that most of these “conserved” elements in the genome are not 
functional as developmental enhancers during zebrafish development. Our data clearly 
indicates that even DNA elements which are conserved very stringently over long 
evolutionary time might not be having a functional role as enhancers during development. 
This raises the question- what are these highly conserved pieces of DNA doing in the 
genome? One  possibility is that these elements can function as negative regulatory elements 
as demonstrated recently [31].Other possibility is that these elements are acting in a 
synergistic manner and require other elements together to function. This was also 
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demonstrated by our BAC studies, which show much more extensive expression pattern as 
compared to the individual CNEs. Also the possibility exists that some of these enhancers 
require the gene specific promoter to function and hence there was no activity with our 
heterologous promoter. This is one of the reasons to employ BAC modification which allows 
us to keep the reporter gene (EGFP) under the control of the endogenous gene promoter. But 
even accounting for the fact that some of these can act as negative regulatory elements or 
function in synergistic manner does not fully explain why the majority of these DNA elements 
are non functional in an enhancer assay. The other strong evidence for the fact that some of 
these elements could truly be non functional came from a study [168] where the researchers 
reasoned that if ultraconserved elements are as vital as predicted by theory, then deleting them 
from the genome should cause severe abnormalities that result in infertility or death. The 
researchers increased the probability of seeing an effect by carefully choosing the elements for 
deletion. The elements had to not only function as enhancers when inserted near a reporter 
gene in transgenic mice, but also reside near genes that produce profound phenotypes when 
disturbed due to mutations. The researchers identified 4 such elements meeting their criteria 
and engineered knockout mice which lacked one of the four elements. The transgenic strains 
all survived and reproduced as expected. Their offspring showed no appreciable differences in 
viability or litter size compared to their control (wild type) littermates and no anomalies in 
body weight, age, or survival. The researchers also ran standard clinical chemistry tests for 
signs of disease, as well as expression analyses of the genes near each element; these tests 
revealed only modest differences between the transgenic and wild-type offspring and there 
were no clearly identifiable phenotype. Mutations in genes near each of the other 
ultraconserved elements revealed a range of similarly lethal or severe abnormalities, ranging 
from neurological and sexual disorders to defective eye and kidney development. But in no 
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case did the researchers find comparable aberrations in mice lacking the adjacent 
ultraconserved elements. These results challenge the prevailing notion that all highly 
conserved elements necessarily encode essential functions. Conversely a study by Andrew 
McCallion’s group reported that even DNA elements with no sequence level conservation 
between human and fish could function as developmental enhancers [169]. In this study the 
authors identify conserved non coding human sequences, comparing a ~ 200 kb segment 
encompassing the human RET locus with the orthologous genomic intervals in 12 nonhuman 
vertebrates. They selected sequences shared among human and at least three non primate 
mammals. In total 13 HCS (human conserved sequence) amplicons, encompassing 28 discrete 
conserved sequences were generated for analysis.  They also compared the genomic sequence 
of a ~200 kb segment encompassing the zebrafish Ret gene with the orthologous interval in 
fugu using AVID/VISTA. They generated 10 ZCS (zebrafish conserved sequence) amplicons, 
corresponding to 14 discrete non coding sequences. They reported that all but one ZCS 
amplicon drove reporter expression consistent with endogenous Ret expression and 
surprisingly 11 out of 13 HCS amplicons drove expression in cell populations consistent with 
zebrafish Ret, this in spite of the fact that there were no sequence level homology between the 
HCS and the zebrafish genome at the Ret locus. Thus our data taken together with previous 
studies clearly suggest that functional information is conserved in vertebrate sequences at 
levels below the radar of large scale genomic sequence alignments. One explanation is that 
orthologous enhancer elements control expression of genes, but has evolved beyond 
recognition through small changes in TFBSs, rearrangement of sites within enhancers, or 
multiple coevolved changes. Examination of enhancer evolution in Drosophila species reveals 
examples of these types of sequence changes, confounding traditional sequence alignment 
approaches while preserving enhancer function across species [170, 171]. Comparison of 
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human and mouse enhancer sequences suggests that similar widespread turnover of TFBSs is 
observed in vertebrate evolution [172]. The authors mapped the binding of four tissue-specific 
transcription factors (FOXA2, HNF1A, HNF4A and HNF6) to 4,000 orthologous gene pairs 
in hepatocytes purified from human and mouse livers. Despite the conserved function of these 
factors, from 41% to 89% of their binding events seem to be species specific. When the same 
protein binds the promoters of orthologous genes, approximately two-thirds of the binding 
sites do not align. The authors concluded that the cross-species variation cannot be explained 
by changes in the sequence specificity of the transcription factors, nor can it be predicted 
based solely on the conservation of binding sequences in the two species. 
Recently Galih and co-workers generated ChIP-seq libraries for OCT4, NANOG and CTCF 
genome-wide binding profiles in human ESCs and compared them with existing ChIP-seq 
libraries generated from mouse [173]. CTCF, an insulator protein, which has a relatively 
consistent binding pattern in different cell types [174], had 16.7% of their genes bound in 
human, also bound in mouse [173]. Strikingly, only 2% and 1.9% of the genomic regions 
occupied by OCT4 and NANOG, respectively were homologously occupied by their 
respective factors in mouse ESCs. Even when the top 10% of the most enriched regions were 
analyzed, OCT4 and NANOG only had 3.8% and 5.3% of conserved regions, respectively 
whereas CTCF had almost 50% of their regions conserved. Taken together, the Oct4 and 
Nanog binding in both mouse and human is indeed markedly different and only a fractional 
overlap is shared between both species. 
Interestingly, some of the differences between the bound sites in both species have been 
attributed to the insertion of transposable elements. Transposable elements were found to 
comprise up to 25% of the bound sites in both human and mouse. These binding sites, which 
markedly coincide with transposable elements, were termed repeat associated binding sites 
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(RABS). Strikingly, about 20% and 15% of the OCT4 and NANOG binding regions, 
respectively are RABS, whereas in mouse ESCs, about 7% and 17% of the Oct4 and Nanog 
binding sites, respectively are accounted for by RABS. This dense occurrence of transposable 
elements at OCT4 and NANOG sites suggests that transposable elements might have rewired 
the transcriptional circuitry in pluripotent stem cells after insertion into the genome. However, 
despite the high occurrence of RABS in both species, barely 1% of the OCT4 RABS regions 
are also homologously bound in mouse. This disparity can be in part accounted for by the 
presence of species-specific transposable elements.  
6.3 Redundant enhancers 
The other interesting data our study revealed was the presence of multiple conserved 
enhancers for the same domain of expression in two of the genes analyzed (Otx1b and Pax9). 
ChIP-chip studies followed by functional validation in Drosophila embryos have also shown 
that many target genes for the transcription factor Dorsal has multiple enhancers controlling 
their expressions. Our data seems to suggest that such multiple enhancers for same similar 
expression domains are a much more pervasive phenomenon than previous thought. But why 
do genes have multiple enhancers for the same domain? They might help ensure precise and 
reproducible patterns of gene expression during embryogenesis. It is possible that redundant 
enhancers are pervasively used in animal development. For example, the mouse sonic 
hedgehog gene is regulated in the floorplate of the embryonic neural tube by two separate 
enhancers with slightly distinct activities [175]. In Medaka  the olSix3.2 gene has 10 CNEs in 
a 4.5 kb genomic region around it which contain all its regulatory elements and deletion 
studies have shown that many of these are redundant in function [176]. Similar studies 
looking  at CNEs in the mouse Sox10 locus have uncovered many cis-regulatory 
elements.These possible enhancers of the Sox10 gene mediate Sox10 expression in the otic 
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vesicle, in oligodendrocytes and in several neural crest derivatives including the developing 
peripheral nervous system and the adrenal gland. They furthermore exhibit overlapping 
activities and share binding sites for Sox, Lef/Tcf, Pax and AP2 transcription factors [147]. 
Multiple redundant enhancers can also explain why deletions of well defined enhancers 
sometimes produce no apparent mutant phenotypes [177]. Multiple conserved enhancers 
might arise from duplication, comparable to the duplication and divergence of protein-coding 
sequences. The evolution of cis-regulatory DNA is a major mechanism driving animal 
diversity. However, there is the potential problem that such change could compromise 
essential genetic activities. Multiple enhancers have the potential to evolve novel binding sites 
and achieve new regulatory activities without disrupting the core patterning functions of 
critical developmental control genes.  
6.4 Zebrafish in the world of conservation 
Taken together our data clearly demonstrates that high levels of functional conservation of 
genes is not necessarily associated with sequence conservation of their corresponding 
regulatory elements. Moreover, highly conserved non-coding elements may not have known 
role in cis-regulation.. But more and more evidence is gathering that the loss of function of 
these conserved elements is a genome wide phenomenon between fishes and other vertebrates. 
A study reported that only 10% of 104 mouse enhancers experimentally validated have 
homologous sequences in zebrafish [166], and several reports have suggested that the genome 
has changed rapidly in the teleost lineage. There was whole genome duplication (WGD) very 
early in the teleost radiation [178, 179]. The duplication would have brought about radical 
remodeling in the teleost genome, being accompanied with gene degeneration and 
complementation [180]. Thus the loss of activity or the presence of enhancer elements that are 
not constrained in sequence between zebrafish and mammals is not surprising. Studies by 
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other groups looking at single genes at a time have also started revealing similar trends in 
other genomic loci in the zebrafish [181, 182] and our data aligns with these studies. But we 
provide robust data over 4 unrelated loci in the zebrafish to show that that relying on standard 
methods to detect evolutionary constraint overlooks significant functional information. But 
there is a need to interpret these data with caution as the teleost radiation occurred 300–400 
million years ago and thus, zebrafish and fugu are separated by a much larger evolutionary 
distance than mammals and this may also, in part, explain the lack of observable alignment or 
constraint.  
6.5 Neutral Evolution and non-coding DNA 
Although the amount of the human genome that harbors functional, yet non-coding, elements 
remains ill-determined, models of sequence evolution are unanimous in predicting at least as 
much functional non-coding sequence as protein coding material in the genome [183, 184].  
The question is how much human DNA, during evolution, has been purified of deleterious 
mutations (‘purifying selection’); how much has accepted mutations because of their benefit 
(‘positive selection’) and thus what remaining proportion of the human genome has 
accumulated mutations that have not been selected for or against (‘neutral evolution’)? 
Because of their abundance and their ease of estimation from aligned sequences, nucleotide 
substitutions have provided the principal mutational signature from which neutrality or 
selection has been inferred. 
Three distinct classes of nucleotides have often been considered as having evolved neutrally: 
pseudogenes, the remnants of defunct genes or reverse-transcribed messenger RNA [185], 
ancestral repeats, the debris of transposons present in the last common ancestor of, for 
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example, human and mouse [184] and 4-fold degenerate (4D) sites, the third position of 
codons that encode one particular amino acid whichever base is present [186]. 
Substitution rates in these putatively neutral sequences may well be relatively constant in 
small (<100 kb) regions, but certainly vary dramatically across mammalian genomes [186-
188] (Fig 14). Why this is so remains unclear, although there are predicted contributions to 
this variation from the hypermutability of CpG dinucleotides [189] from recombination [190], 
from the repair of sequence transcribed in the germ-line [191] and from base composition not 
being at equilibrium [192]. 
The higher abundance of non-coding over coding sequence within the constrained portion of 
the human genome indicates that the majority of functional sequence is non-coding. It thus 
appears possible that recent adaptive events too might have involved more non-coding than 
coding sequence. Despite this, most attention has been paid to detect positive selection in 
coding sequence. Partly, this is because protein-coding sequence is more easily identified and 
annotated and partly because synonymous sites can be exploited to provide an estimate of the 
local neutral rate against which substitution rates within proximal non-synonymous sites can 
be compared [193, 194]. In contrast, predicting positive selection in non-coding sequence is 
hindered by the difficulty of identifying functional sequence when it has rapidly evolved, by 
the lack of proximal presumed neutral sites and by variations in neutral rate [195]. Though 
there has been some recent studies showing that functional non coding sequences have 
evolved rapidly in humans as compared to other primates giving them a human specific nature 
[196].  
The division of genomic DNA into the well-known trichotomy of neutral, conserved and 
positively selected sites is, of course, an over-simplification. In particular, it does not consider 
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sequence whose functionality has been intermittent over the long timescales separating 
mammalian species. The impermanence of functional sequence is most apparent within 
transcription factor binding sites [169]. On the basis of limited experimental data, it is 
estimated that approximately one-third of these sites in human or rodents are not functional in 
the other species [197]. If selection were often to be fleeting, rather than permanent, it would 
begin to explain the increasingly common identification of functional sequence that has not 
been conserved between diverse mammals. There are thousands of newly identified Piwi-
interacting RNAs, for example, that are not conserved between mouse and more distant 
species [198]. More generally, large numbers of non-coding sequences exhibit divergence 
levels, between mouse and either human or rat, that are similar to those of putatively neutral 
sequence [199, 200]. If such sequences are indeed rapidly interchanging between neutrality 
and functionality, then our model organisms will not yield experimental findings on these 
sequences that are sufficiently relevant to human biology. Comparative genomics will remain 
central to the study of selection, but current evolutionary models and statistical techniques 
will need to be adapted to cope with transiently selected sequence. Moreover, the genomic 
data we currently have to hand will be too coarse grained: we will need to determine the 
genome sequences of more nearly related species in order to investigate the more rapid 




Fig 14: Phylogenetic tree based on neutral evoloution   
Branch lengths describe numbers of Substitutions per Site in aligned positions. A substitution per Site 
is the unit of evolutionary change. This figure shows the approximate neutral rate of evolution, in 











6.6 Concluding remarks 
Clearly a lot more information about the nature of conserved non coding elements in the 
genome remains obscure. Their identification by looking at sequence level constrains have 
provided a starting point for looking at functional elements in vertebrate genomes. However, 
two common misconceptions arise from this somewhat adventitious approach. First, not all 
functional elements can be captured by this means, not least because sequence conservation 
has low resolving power, but also because functional elements do not necessarily rely solely 
on primary sequence and are often very short. Second, not all regulatory languages are 
conserved across large evolutionary distances; different animal lineages might have evolved 
independent, yet parallel regulatory networks that use orthologous genes, but completely 
unrelated inputs. The most tractable sets of conserved non coding sequences have been 
gathered by skimming off the very top of the pile (e.g. ultraconserved elements) or by using 
large evolutionary distances (e.g. conserved non coding elements). Despite preliminary efforts 
to characterize these functionally, little is known about how the sequence within these 
elements determines their function and how one can filter out the noise from the signal in a 
high throughput manner. It is clear that the most highly conserved non coding sequences 
associate with developmental regulators, suggesting a key role in the orchestration of early 
embryo development. However, despite this, there is at least some evidence that deleting 
individual elements from mice does not have any clearly identifiable phenotype [168] 
It is amply clear that the degree of sequence conservation is not a measure of how ‘important’ 
or ‘crucial’ a functional element might be, but its relevance is shaped by the underlying 
molecular mechanisms that determine its particular function. The constraint on any given 
nucleotide within an element is thus a product of the molecular interactions governed by that 
nucleotide and, to a lesser extent, the interactions at neighboring nucleotides. One of the 
90 
 
fundamental difficulties in predicting functional elements in the genome is that we have little 
understanding of how these constraints are shaped. For example, DNA–DNA or DNA–RNA 
interactions are often highly specific, such that short but exact sequences are recognized (e.g. 
microRNAs). For these sites to change, without a change in function, complementary 
mutations have to co-occur at the same time, such that 100% identity is conserved. This is 
obviously less likely to occur than a single nucleotide change in one site; consequently, these 
sequences are likely to remain highly conserved through evolution. DNA–protein interactions 
involving transcription factors are generally perceived to be somewhat promiscuous, allowing 
DNA sequence plasticity without necessarily affecting function [171], thereby permitting 
sequence change without a functional consequence. Hence, depending upon the restrictions 
imposed by molecular interactions some functional sites may evolve at a faster rate than 
others. However, mutation rates also vary from lineage to lineage; for example, among 
vertebrates, it seems that teleost genomes evolved relatively quickly [201]. Consequently a 
molecular mechanism with a degree of flexibility or redundancy can allow close to neutral 
evolution within a species, thereby abolishing sequence conservation.  
Opposed to this, it is not clear how even minor changes in the DNA sequence of a protein 
binding site might affect the quantitative binding of a transcription factor in vivo, and under 
tightly regulated conditions (such as early development), there may be particularly be a strong 
selective pressure at protein binding sites. Although some functional elements evolved very 
early in vertebrate history, many more are specific to a particular lineage. Functional elements 
are constantly evolving, and it is therefore unreasonable to expect that all functional elements 
will be conserved at the sequence level between any two species. Also most DNA sequences 
as defined by computational algorithms have very stringent criteria to make the cut-off as a 
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conserved element ( Table A2) and hence most relatively smaller binding site sequences have 
failed to make the cut.  
 The length of the highly conserved sequences, and extensive clustering of ultra conserved 
elements and CNEs, possibly suggests that these regions represent the foci of large 
multifunctional modules, with overlapping sets of instructions. This might also account for the 
high levels of sequence conservation seen in these sequences, if each nucleotide has several 
functional constraints placed on it. More diffuse functional regions or isolated functional units 
(e.g. a single TF-binding site) will be much more recalcitrant to comparative sequence 
analysis. Largely because of our lack of understanding of the mechanisms involved and our 
limited ability to functionally ‘assay’ these sequences in a meaningful way in vivo, analyses 
tend toward the identification of potential TF-binding sites and their ability to upregulate gene 
expression in an ‘enhancer-like’ manner. In summary, whereas sequence conservation, 
particularly across large evolutionary distances, is strongly indicative of a functional role, lack 
of sequence conservation does not mean that a sequence does not have a crucial function. 
Also it is worthwhile to remember that non-conserved/variant DNA sequence elements may 
have thermodynamic or structural read-outs that have not been addressed so far mainly due to 
technical limitations. 
It is becoming increasingly clear that elucidating transcription factor binding sites in the 
genome will lead to discoveries of more cis-regulatory elements. With the availability of 
better genome sequence data and also of antibody against all major transcription factors in the 
genome, ChIP-seq will play an increasing role in locating these cis-regulatory elements in the 
genome. As most of these elements harbor multiple transcription factor binding sites, efforts 
will also have to be focused at looking at ChIP-seq data for multiple factors in the genome to 
define individual cis-regulatory module. Indeed a recent study in Drosophila uses such an 
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approach to predict with great accurary,spatio-temporal cis-regulatory activity based only on 
in vivo transcription factor binding and enhancer activity data.[202]. But a word of caution is 
warranted here. As pointed out earlier, the ability to do ChIP on animal tissue is at times 
limited by the amount of material that is available. Also the complexity of the vertebrate 
genome will make predicting how these elements interact and behave more difficult as 
compared to the “simpler” invertebrate model systems like sea urchins. It is also clear that 
most of these cis-regulatory elements cannot be classified based on a single set of  
characteristics and most of these elements will have some unique property which has a role in 
defining its function, be it conservation, binding P300, being marked by certain histone marks 
or others. Also new approaches have to include looking at RNA seq data that is being 
generated to ensure that many of these conserved sites in the genome are actually non –
coding. 
By combining evolutionary, functional and bioinformatics approaches, progress is being made 
into what these sequences do and how they are molded. Nevertheless, there is a pressing need 
to understand how these sequences function at the molecular level and to determine the nature 
of these interactions, so that we can ultimately rely a little less on heuristic models and more 
on the functional biology concealed within 98% of our genome and finally able to decipher in 
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Table A1: The EST clones used to synthesize the insitu hybridization RNA probes for each gene. 
* The EST clone numbers are the reference numbers for each clone in the GIS zebrafish EST library. 
 
  
Gene  EST* Polymerase for in vitro 
transcription 
Nkx3.2 FDR306-P00006-BR_A14 sp6 
Pax9 FDR103-P00067-DEPE-F_G04 sp6 
Otx1b FDR202-P00029_BR_D17 sp6 
































































































Fig.A10: The EGFP reporter construct which was used in all transgenic assays. The fragment was cut 





Fig. A11: Recapitulation of  expression of transgene driven by Dlx5/6 intergenic enhancer. The top 
panel is from reference 104. The bottom panel shows our experiment. White arrow indicates 
diencephalic and telencephalic domains. 
 
 
Abbreviation Term Defination 
UCR Ultra conserved region ≥200 bp 100% conserved 
between human and mouse 
Nontranscribed, ≥50 bp,  ≥95% 
conserved between human and 
mouse, and at least partially 
aligned to fugu 
UCE Ultra conserved element ≥100 bp 100% conserved 
between human and mouse 
CNS Conserved noncoding sequence Nongenic, human:mouse, >100 
bp and with ≥70% identity 
Β – globin promoter 
SmaI EcoRI BamHI 




CNE Conserved noncoding element Nontranscribed, >100 bp 
human:fugu alignments with 
MegaBlast 
HCNR Highly conserved noncoding 
region 
Visual inspection of 
mouse:Xenopus:zebrafish 
alignments 
HCNE Highly conserved noncoding 
element 
Windows ≥50 bp that do not 
overlap coding regions and for 
which the probability of being 
under purifying selection, given 
the conservation score, 
is ≥95% 
CNG Conserved nongenic sequence Nontranscribed, human:mouse 
BLAST with an e-value < 10-20 
and similarity ≥98% 
 
Table A2: Various terminologies used to define conserved non coding sequences in the vertebrate 
























CNE Forward primer Reverse primer 
bx1 5`ATGTTCAGTGTTTCCCGCGT3` 5`TCTGCTCCGATTCAATGAAG3` 
bx2 5`ATCAATCATTTATGTAAGGA3` 5`GTGTGTGTGTGTGTGCACTACCTGCATCAGC3` 
bx3 5`TGTGTGTGTGTGTGTGTGTC3` 5`AACTAAAATGGGTATTATGG3` 
bx4 5`GAAGGACTTTATTTAGGGTG3` 5`CAGAAACACAACTGGGAGAA3` 
116 
 
CNE Forward primer Reverse primer 
px1 5`CCATCATCCTTGTCACCTGG3` 5`CTGGTCATAAACCAGCAGAG3` 
px2 5`CGAAAGAGTCTATTAGGTTT3` 5`GAATAAAACAAAGAGCAAAC3` 
px3 5`AGAAATTAAGGCGAGCAAAA3` 5`CCGACAAGATGAATCGGGAT3` 
px4 5`TCAAACCATTGAGTTCTGTT3` 5`TGTATGTGATTTGTATTGTG3` 
px5 5`AAATTCAAAAAATTCCACAT3` 5`CCCTCCTAAAATTAATAAGA3` 
px6 5`TGCCCCCGTTTTCAAGCTTT3` 5`CTGCAGCCTCGCTAAGTTTT3` 
px7 5`GAGAGGAGCTGCTAAGATAA3` 5`AATAGCAGACCTGGAATTGA3` 
px8 5`TAGTTGATTTTTCATGTGCA3` 5`TGTAGAGAGAGATTCCCAAA3` 
px9 5`ACCTCCAGCATTTCAGCTCA3` 5`CATAGATGTCCTTAAACACA3` 
px10 5`ATGCTGTTATAATAACCCAT3` 5`ATTTAACCCTTGCGATTACT3` 
px11 5`TCCGTCACACCTGTCTTACC3` 5`CAGTGACATTCATGCCCAGC3` 
 
















CNE Forward primer Reverse primer 
ox1 5`TGCATTTTGCTGGTTTACTC3` 5`TCACCAAAGCCCTTCGACCG3` 
ox2 5`TGGAGGGTAGACTGTGACCA3` 5`CAGAAGAAGCTCAGCTCTGT3` 
ox3 5`TCAAATGCAGCAAGCGAGGG3` 5`TATGCCATGACTCCTATTTC3` 
ox4 5`AAAGCAAATAACTCTGAAGT3` 5`TAAAAAGCAAACTCCATTTC3` 
ox5 5`AGTTTTAATATATTATAAAA3` 5`AGCGGGAGTGTGATGGAGAC3` 
ox6  5`AAACACATTTCCGCTGAAGA3` 5`CGTGACAAAAAGAAACTAAT3` 
ox7 5`ACGCTCAAAATTGATATGTT3` 5`ATGTATATACAGTATAGGCT3` 
ox8 5`TAAAGACTGCTGCAAAAAAA3` 5`ACCACTCTGGCTCTCAGGCC3` 
ox9 5`CCTCGCTAGAATCCCCCTTT3` 5`GATGTGAAAAAACTTTAAAC3` 
ox10 5`AGGCCCAGACAGAAGCACTC3` 5`ATACCCTGTTCTACTTCTTC3` 
ox11 5`GTGATGTTTGACGCATATTT3` 5`CTTGACATAGTTATTTTAAT3` 
ox12 5`TCTAGTGCTTGCTGGGACAA3` 5`TATATTTATTTTATTAATCT3` 
ox13 5`TATCAACACTATGCCACAAA3` 5`AGCAGGCTGGTCATTGTCCT3` 
ox14 5`TTCACATCCTAAAGACTGCT3` 5`GGCTAATCATTTTTTAACTG3` 
ox15 5`AGAATCCCCCTTTCCCTGAG3` 5`AATGATTTCTACCAGGATGT3` 










Table A7: The nucleotides in red are the ones mutated (5 bp) with respect to their wild type 




M 1-10 AGATGGAGAGGCCTTTCTCTTTCTTTCTTTCTCTCCCTCT 
M 11-20 CTCGTTCTCTTAAGGGAGAGTTCTTTCTTTCTCTCCCTCT 
M 21-30 CTCGTTCTCTGCCTTTCTCTGGAGGGAGGGCTCTCCCTCT 
M 31-40 CTCGTTCTCTGCCTTTCTCTTTCTTTCTTTAGAGAAAGAG 
 
Table A8: The nucleotides in red are the ones mutated (10 bp) with respect to their wild type 
sequence in EM4 
 
 
CNE Forward primer Reverse primer 
fx1 5`CTGTCAGGAGGAATTAAAGT3` 5`TTTACAAATCATTTTTGTTG3` 
fx2 5`AGATGTCTTATAGGCTCATG3` 5`AGTGAAAGAAGTTTGCCTG3` 
fx3 5`CATCCAACACTGTTGTCAAA3` 5`AATTTAGCATAATTTCCATG3` 
fx4 5`TTAGCATTAATGTACAATGA3` 5`TCAAAAGAACAGCATTCATT3` 
fx5 5`TTTAAACCTGTTTTCAAGAC3` 5`GACTGGCCCTATAATACACA3` 
fx6 5`TATTATTATTGTTGTTGTTG3` 5`GTGGGAGAGAGAGTCTTCAT3` 
fx7 5`CTGTTCAAGCGTCAAATTAT3` 5`TTTCTCCTTCAACTTGAATA3` 
fx8 5`GAAGCCTGGCCACACTCATA3` 5`TGGCATTTCACCAATCATCC3` 
fx9 5`TGCTTAATTAAGAATCCACA3` 5`TGAGTGTGCTTTTCTTTTTA3` 
Name Sequence 
EM4 CTCGTTCTCTGCCTTTCTCTTTCTTTCTTTCTCTCCCTCT 
Probe 1 AGATGTCTCTGCCTTTCTCTTTCTTTCTTTCTCTCCCTCT 
Probe 2 CTCGTGAGAGGCCTTTCTCTTTCTTTCTTTCTCTCCCTCT 
Probe 3 CTCGTTCTCTTAAGGTCTCTTTCTTTCTTTCTCTCCCTCT 
Probe 4 CTCGTTCTCTGCCTTGAGAGTTCTTTCTTTCTCTCCCTCT 
Probe 5 CTCGTTCTCTGCCTTTCTCTGGAGGTCTTTCTCTCCCTCT 
Probe 6 CTCGTTCTCTGCCTTTCTCTTTCTTGAGGGCTCTCCCTCT 
Probe 7 CTCGTTCTCTGCCTTTCTCTTTCTTTCTTTAGAGACCTCT 
Probe 8 CTCGTTCTCTGCCTTTCTCTTTCTTTCTTTCTCTCAAGAG 
118 
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